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Abbreviations 
Aβ amyloid-beta 
AD Alzheimer's disease 
Arg-1 arginase-1 
ASD autism spectrum disorder 
ATP adenosine-5′-triphosphate  
AVP arginine vasopressin 
AVPR1a arginine vasopressin receptor 1a 
BBB blood-brain barrier 
BD bipolar disorder 
BDNF brain-derived neurotrophic factor  
C3 or C4 complement component 3 or 4 
CC corpus callosum 
Chi3l3 chitinase 3-like 3 
CNS central nervous system 
CR3 complement receptor 3 
CSF-1 colony stimulating factor 1 
Csf-1R colony stimulating factor 1 receptor 
CX3CL1 CX3C chemokine ligand 1  
CX3CR1 CX3C chemokine receptor 1 
DAP12 DNAX activation protein of 12 kDa 
DISC disrupted-in-schizophrenia  
GR glucocorticoid receptor 
GWAS genome-wide association study 
HPA hypothalamus-pituitary-adrenal axis 
IFN-α/γ interferon-alpha/gamma  
IL-1β/4/6/10/13/34 interleukin-1β/4/6/10/13/34 
KO knockout 
LPS lipopolysaccharide 
LTP long-term potentiation 
MHC major histocompatibility complex 
MIA maternal immune activation  
MPD mouse phenome database  
Nos2 nitric oxide synthase 2 
OXT oxytocin 
OXTR oxytocin receptor 
P2R purinergic receptor  
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PFC prefrontal cortex 
PPI prepulse inhibition of startle response 
PSNS Parasympathetic nervous system 
SNS sympathetic nervous system 
SNRIs serotonin-norepinephrine reuptake inhibitors 
SSRIs selective serotonin reuptake inhibitors 
TGF-β transforming growth factor-beta 
TNF-α tumor necrosis factor-alpha 
TREM2 triggering receptor expressed on myeloid cells 2 
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Abstract 
Interactions between the brain and the immune system provide a complex 
microenvironment for brain development. Furthermore, these interactions cause 
behavioral changes in rodents and humans. Multiple molecules of the immune 
system in the brain can regulate neural development. Microglia, the resident 
phagocytes in the central nervous system (CNS), dynamically survey their 
microenvironment to maintain brain homeostasis. Microglia also actively 
respond to neuroinflammation induced by insults such as stress, injury, or 
infection. A dysfunctional immune system in the brain may cause aberrant brain 
development and adulthood behavior. Dysfunctional immune regulation has also 
been implicated in the pathophysiological progression of neuropsychiatric 
disorders in rodents and humans.  
 
The major goal of my thesis is to characterize brain immune genes, gene networks, 
and neuropeptides in inbred mouse strains. These factors might contribute to 
mouse anxiety- and sociability-like behavior related to symptoms in generalized 
anxiety disorder and schizophrenia, as inbred strains such as C57BL/6J(N) 
(C57BL/6J and C57BL/6N) and DBA/2J differ in their anxiety-, sociability- and 
sensorimotor gating-related behaviors.   
 
In this thesis, we utilized eight inbred mouse strains—129S1/SvImJ, A/J, 
BALB/cByJ, C3H/HeJ, C57BL/6J, DBA/2J, FVB/NJ, and SJL/J—to investigate 
the contributions of brain immune genes and gene networks to social behavioral 
phenotypes. We first analyzed brain transcriptomics from eight inbred strains to 
detect differentially expressed immune genes. By correlation analysis, we then 
predicted the associations of these genes of interest with the animal behavior and 
brain morphology. Compared to female C57BL/6N mice, we observed high 
expression of cortical Il1b and Il6 and reduced expression of Cx3cl1 in female 
DBA/2J mice. Furthermore, male DBA/2J mice had lower levels of C1qb and 
H2-d1 in the brain compared to male C57BL/6J mice. Interestingly, the 
hippocampal mRNA level of C1qb was positively correlated with the time spent 
in social interaction processes in male DBA/2J mice but not C57BL/6J mice. We 
also investigated differences in cytokine expression and microglial signature 
gene (for M1-M2 polarization) expression among male C57BL/6J, FVB/N, 
DBA/2J and 129S2/Sv mice following systemic LPS challenge. Il1b, Il6, and Tnf 
were highly expressed in the hypothalamus of DBA/2J mice without LPS 
stimulation. After LPS challenge, the microglial proinflammatory M1-type 
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signature gene Nos2 was highly expressed in the hypothalamus of DBA/2J mice 
compared to the mouse strains FVB/N, DBA/2J, and 129S2/Sv.  
 
We further found that social stress modulated anxiety-like and social behavior in 
female C57BL/6N and DBA/2J mice in a different manner. The experimental 
mice were divided into three groups: separate-housed C57BL/6N mice, separate-
housed DBA/2J mice, and mix-housed C57BL/6N and DBA/2J mice. Mixed 
housing made socially active C57BL/6N mice more vulnerable to anxiety and 
social deficits compared to socially withdrawn DBA/2J mice. Furthermore, 
expression of glucocorticoid receptor Nr3c1 was attenuated in the hippocampus 
and cortex of mix-housed C57BL/6N mice compared to the separate-housed 
C57BL/6N mice. Mix-housed C57BL/6N mice also had a higher level of cortical 
Avpr1a, but a lower level of hippocampal Oxtr than mix-housed DBA/2J mice. 
Separate-housed DBA/2J mice had a higher level of hypothalamic Oxtr 
compared to the separate-housed C57BL/6N mice. These results imply a 
significant differential impact of social intervention on anxiety-like and social 
behavior between C57BL/6N mice and DBA/2J mice. 
 
In conclusion, my thesis revealed that brain immune genes and neuropeptides are 
associated with neuropsychiatric-like (anxiety-like and social deficits) behavior 
in mice. These observations may provide insight on the potential pathogenic 
molecular mechanisms of neuropsychiatric disorders. 
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1. Introduction 
Interactions between the brain and the immune system during adulthood have 
been implicated in both brain development and behavioral changes, including 
mood and cognition (Bilbo and Schwarz, 2012). A dysfunctional immune system 
in the brain, either overactive or inactive, causes aberrantly biased pro/anti-
inflammatory cytokine production and immune gene expression. These changes 
may contribute to the pathogenesis of neuropsychiatric disorders such as anxiety, 
depression, schizophrenia and autism (Dantzer et al., 2008; Khandaker et al., 
2015; Onore et al., 2012). Microglia, an important innate immune modulator in 
the brain, play critical and diverse roles in the brain. A balanced microglial 
polarization is essential to control their functional phenotypes within the CNS in 
response to microenvironmental factors (Nakagawa and Chiba, 2014; Saijo and 
Glass, 2011). Several important brain immune-related genes participate in the 
regulation of microglial functions, such as synaptic pruning. These genes are also 
involved in some neuropsychiatric disorders (Schizophrenia Working Group of 
the Psychiatric Genomics, 2014; Stevens et al., 2007; Wolf et al., 2013; Wu et 
al., 2015; Zhan et al., 2014). Therefore, understanding how 
microglia/macrophages and associated immune genes contribute to these 
disorders is of central importance in identifying fundamental pathogenic 
mechanisms and developing new therapeutic interventions. 
 
1.1 Mouse anxiety- and sociability-related behavior resembling symptoms 
of patients with neuropsychiatric disorders  
Anxiety is a common emotional response to threatening stimuli. With increased 
severity and prolonged exposure, the general responses to the stimuli may transit 
to complex anxiety-associated mental disorders such as generalized anxiety 
disorder, post-traumatic stress disorder, major depressive disorder, bipolar 
disorder, schizophrenia, and autism. These mental diseases are responsible for 
significant health, social, and economic burdens globally (Collins et al., 2013). 
Anxiety and social deficits are two major symptoms identified in the above-
mentioned neuropsychiatric disorders (American Psychiatric Association DSM-
5 Task Force., 2013). It is important to investigate the underlying neurobiological 
mechanisms to understand these behavioral aspects in neuropsychiatric disorders. 
There are several advantages in using mouse models to study neuropsychiatric 
disorders. Due to ethical and empirical limitations of human studies, suitable 
mouse models are used to recapitulate some key features of a disease. Mouse 
models are useful in characterizing the phenotypes and mechanisms of 
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neuropsychiatric disorders (Holmes et al., 2002; Olivier et al., 2001; Voikar et 
al., 2005). Inbred mouse strains are also commonly used to characterize mouse 
behavioral phenotypes, including anxiety, locomotor activity, sociability, 
learning and memory, aggressive behavior, sensory motor gating, and drug-
induced behaviors (Crawley et al., 1997). Finally, human epidemiological and 
genetic studies, such as genome-wide association studies (GWAS) in several 
neuropsychiatric disorders, have revealed candidate genes in those diseases. 
However, the underlying mechanisms regulated by the candidate genes still need 
to be investigated in appropriate mouse models (Hovatta and Barlow, 2008; 
Sokolowska and Hovatta, 2013). My thesis on anxiety-like and social behavior 
in inbred mouse strains aimed to clarify the mechanisms contributing to the 
pathogenesis of neuropsychiatric disorders. 
 
1.1.1 Anxiety-like and social behavior in mice 
Anxiety-like and social behavior have been studied in mouse and rat behavioral 
laboratories, in particular in inbred mouse strains. Accordingly, several standard 
behavioral tests and paradigms are relatively reproducible and acceptable among 
inbred mouse strains (Holmes et al., 2002; Moy et al., 2004). Genetic divergences 
among inbred strains are important for the appropriate interpretation of 
transgenic and knockout mice behavior (Bothe et al., 2004). It is therefore 
necessary to use inbred mouse strains to study anxiety-like and social behaviors 
when investigating related scientific questions (Krackow et al., 2010; Wahlsten 
et al., 2006). As housing and environmental issues affect animal behavior, these 
external factors should be carefully considered before and during the experiments 
(Crabbe et al., 1999; Wahlsten et al., 2003).  
 
1.1.1.1 Tests of anxiety-like behavior in mice 
? Open-field test 
The utility of this test was first demonstrated through comparing the effects of 
anxiolytic drugs on aggressive and exploratory behaviors in mice (Christmas and 
Maxwell, 1970). The open-field test provides an effective way to assess the 
spontaneous response of an experimental animal to a novel environment and the 
animal locomotor activity. Once an experimental mouse is placed in the chamber, 
the mouse shows exploratory activities and basic movements such as rearing up 
and moving around the walls and corners. The mouse further displays preferences 
to the center or the corner. To evaluate the anxiety and locomotor activity of the 
experimental mouse, several parameters are recorded. These include the total 
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travel distance, the time spent in the center, and the number of rearing up motions. 
The amount of feces produced by the mouse is also recorded, as this parameter 
can reflect the extent of anxiety in the mouse in response to the test. This test 
provides a means to screen potential drugs for therapeutic intervention on 
anxiety-like behaviors in animal models. Accordingly, it has been broadly used 
in assessing exploratory ability and anxiety-like behaviors in mice and rats.  
 
? Light/dark test 
This test was developed to measure the anxiolytic effect of benzodiazepines and 
to assess for anxiety-like behavior (Crawley and Goodwin, 1980). The test 
chamber has both a lighted compartment and a dark compartment. Once an 
experimental mouse is placed in the open chamber, the mouse explores the novel 
environment and transits between the two compartments. Since mice naturally 
prefer dark environments, they usually prefer to stay longer in the dark 
compartment. To evaluate the exploratory ability and anxiety-like behaviors of 
the experimental mouse, several parameters are measured. These include the 
transition number between the two compartments, the number of rearing up 
motions, and the amount of feces. 
 
? Elevated plus-maze test 
This test was initially used to assess anxiolytic and anxiogenic drug effects on 
exploration in rats (Pellow et al., 1985). The test was then gradually used to 
evaluate anxiety-like behaviors in mice (Lister, 1987). The test uses an elevated, 
plus-shaped (+) apparatus with two open and two enclosed arms. An 
experimental mouse is placed into an open arm in elevated-plus maze to explore 
the novel and stressful environment. The mouse naturally prefers moving to and 
staying in the protected enclosed arm. To evaluate the exploratory ability and 
anxiety-like behaviors of the experimental mouse, several parameters are 
measured. These include the transition number between the open and the 
enclosed arm, the time spent in each arm, and the amount of feces. By providing 
a relatively brighter and open area, the elevated plus-maze test is a more stressful 
environment to mice compared to the open-field and light/dark tests.  
 
1.1.1.2 Tests of social behavior in mice 
? Social dominance: Tube test 
This test has been widely used to validate social behavior among both inbred and 
genetically modified mice (Lindzey et al., 1961; Long et al., 2004; Spencer et al., 
2005). In this test, two mice, unfamiliar to each other before the test, are released 
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simultaneously from opposite ends of a transparent plastic tube (3 cm in inner 
diameter, 30 cm in length). When one mouse completely retreats from the tube, 
the mouse remaining in the tube is designated the winner. The mouse that 
retreated is the loser. If the test lasts more than 2 min or if the mice cross over 
each other, no score is drawn. The win percentage is calculated for each mouse. 
The test is relatively easy to perform in characterizing social behaviors in mouse 
models, as compared to the other social behavioral tests described below. 
 
? Social interaction: Resident-intruder test 
Since mice prefer social and group habituation, a reciprocal social interaction test 
is a useful approach to study mouse sociability. In this test, a resident mouse stays 
in its home cage, and then an intruder mouse is placed into the cage. The test 
records several parameters including sniffing, chasing, following, and hetero-
grooming (licking and cleaning the fur of each other) between the mice (Crawley, 
2007). The cage, as a novel environment, can induce anxiety-like behavior in the 
intruder mouse. Accordingly, both anxiety- and social-related behaviors of the 
experimental mouse can be evaluated in the test (File and Hyde, 1978; File and 
Seth, 2003). 
 
? Social approach: Three-compartment chamber test 
The three-compartment chamber test is used to evaluate recognition of social 
novelty of a mouse, with each side compartment of the chamber containing an 
empty transparent holder (Nadler et al., 2004). An experimental mouse is placed 
into the middle compartment of the chamber and allowed to habituate for 10 min. 
A gender- and age-matched mouse, unfamiliar to the experimental mouse, is then 
placed into one of the holders, and the experimental mouse is placed back to 
explore the whole apparatus for 10 min. The experimental mouse is video 
recorded. The percentage of time the experimental mouse spent sniffing each 
holder is calculated.  
 
Several other social behavioral tests are also utilized to evaluate sociability. 
These include the social preference-avoidance test, social approach-avoidance 
test, and partition test (Moy et al., 2007; Toth and Neumann, 2013). Notably, 
many social interaction tests are conducted in environments that invoke to a 
certain extent exploration and enhance anxiety of the animals (File and Hyde, 
1978; File and Seth, 2003; Lightowler et al., 1994; Sajdyk and Shekhar, 1997). 
It is therefore necessary to carefully consider whether locomotor activity and 
anxiety-like genetic related phenotypes confuse the interpretation of social 
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behavioral results.  
 
1.1.2 Anxiety- and sociability-related symptoms in patients with 
neuropsychiatric disorders 
Anxiety and social deficits are core symptoms in multiple neuropsychiatric 
disorders (American Psychiatric Association DSM-5 Task Force., 2013; Karelina 
and DeVries, 2011; Tandon et al., 2009). Based on these core symptoms, 
behavioral neuroscientists have further explored and established the correlated 
anxiety and social deficits paradigms in animal disease models to characterize 
the underlying disease mechanisms. 
 
1.1.2.1 Generalized anxiety disorder 
Generalized anxiety disorder is characterized by a core symptom of persistent 
and excessive worry about everyday life. This core symptom of worry leads to 
concentration difficulties and other nonspecific psychological and physical 
symptoms, such as restlessness, insomnia, fatigue, headache, sleep disturbance, 
and muscle tension (American Psychiatric Association DSM-5 Task Force., 
2013). For diagnosis of generalized anxiety disorder, these symptoms must be 
persistent and ongoing for at least six months. The anxiety, worry, or associated 
physical symptoms cause clinically significant distress or impairment in mental 
functioning. Epidemiological studies reveal that gender dimorphism exists, with 
prevalence being approximately two times higher among women (Kessler and 
Wang, 2008). 
 
1.1.2.2 Post-traumatic stress disorder 
Post-traumatic stress disorder, the fifth most common psychiatric disease, is a 
common anxiety illness (Guina et al., 2016; Hoge et al., 2014; Steel et al., 2009). 
Post-traumatic stress disorder symptoms appear after an individual experiences 
traumatic events such as combat, terrorist attack, violent crimes, or natural 
disasters such as floods, fires, and earthquakes. The characteristic symptom is 
persistent memory of the traumatic events, leading to actual avoidance of 
circumstances or stimuli resembling or associated with the trauma (Karam et al., 
2010; Keane, 2009). Post-traumatic stress disorder is associated with substantial 
comorbidities, such as depression and anxiety (Brunello et al., 2001). Several 
antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or 
serotonin-norepinephrine reuptake inhibitors (SNRIs) have shown some 
beneficial effects on post-traumatic stress disorder (Hoskins et al., 2015; Jeffreys 
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et al., 2012). In addition, some post-traumatic stress disorder patients show 
symptoms such as suicidality, dissociation, persistent negative trauma-related 
emotions (e.g., anger, guilt, shame), and limited work and social functioning 
(Kessler et al., 1995).  
 
1.1.2.3 Major depressive disorder 
Major depressive disorder is characterized by altered mood, cognitive 
impairment, vegetative, and even psychotic symptoms that cause deficits in 
proper life functioning (Nestler et al., 2002; Roiser et al., 2012). The symptoms 
include low self-esteem, feelings of hopelessness, impaired concentration, weight 
changes, and decreased interest in pleasurable stimuli (American Psychiatric 
Association DSM-5 Task Force., 2013). Epidemiologic studies show that roughly 
40–50% of the risk for depression is genetic (Nestler et al., 2002). However, non-
genetic factors are also important. For example, social isolation has been 
identified as a risk mediator for depression, and avoidance of social contact and 
increased anxiety are observed in late life of depressive patients (Heikkinen and 
Kauppinen, 2004). Twin studies reveal that social isolation and loneliness are 
associated with depression in both young and old adults (Courtin and Knapp, 
2015; Matthews et al., 2016).   
 
1.1.2.4 Bipolar disorder 
Bipolar disorder is a chronic psychiatric condition characterized by periods of 
depression and mania, as well as cognitive impairment. Bipolar disorder is 
associated with a significantly lower quality of life and higher rates of suicide 
compared to the healthy population (Novick et al., 2010). Two different types of 
bipolar disorder, bipolar disorder I and bipolar disorder II, differ dimensionally 
(e.g. by severity or duration) (American Psychiatric Association DSM-5 Task 
Force., 2013). Bipolar disorder I is termed as manic-depressive illness. Manic 
symptoms include irritability or euphoria along with symptoms such as insomnia, 
impulsive behavior, increased activity, rapid thought processes, and 
distractibility. Manic symptoms usually last at least one week in bipolar disorder 
I patients. Some people with bipolar disorder I may experience depression, but 
depressive episodes are not required for the diagnosis of bipolar disorder I. 
Bipolar disorder II is defined by at least one hypomanic episode, along with at 
least one episode of major depression. Hypomania is characterized by the same 
symptoms as mania but lasts for shorter intervals. Despite the substantial 
differences in duration and severity between manic and hypomanic episodes, 
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bipolar disorder II disorder is not a “milder form” of bipolar disorder I. Compared 
to individuals with bipolar disorder I, individuals with bipolar disorder II have 
greater chronicity of illness. Additionally, most people with bipolar disorder II 
more often suffer from episodes of depression. Mood instability causes serious 
impairments in work and social functioning in bipolar disorder II patients. Mixed 
episodes including manic/hypomanic and simultaneous depressive symptoms 
exist in both bipolar disorder I and bipolar disorder II patients (American 
Psychiatric Association DSM-5 Task Force., 2013). Bipolar disorder patients 
likely have comorbid disorders, such as generalized anxiety disorder, panic 
disorder, and substance abuse (Kessler et al., 2005; Otto et al., 2006).  
 
1.1.2.5 Schizophrenia 
Schizophrenia is a chronic psychotic disorder that affects around 1% of the 
population in their lifetimes. The characteristics of schizophrenia are divided into 
three main categories: positive symptoms, negative symptoms, and cognitive 
deficits in patients (MacDonald and Schulz, 2009; Tandon et al., 2009). The 
positive symptoms include delusion and hallucination. The negative symptoms 
include alogia (poverty of speech), anhedonia (inability to feel pleasure), apathy 
(lack of interest), affective flattening (reduction of emotional expression), and 
avolition (lack of motivation). Cognitive deficits include impairments in working 
memory, attention, information processing, and executive functioning. Impaired 
social function or cognition is a critical endophenotype among schizophrenia 
patients (Carpenter et al., 1988; Penn et al., 2008). The first acute phase 
symptoms in schizophrenia include anxiety, depression, and concentration 
deficits. With the pathophysiological progression of schizophrenia, negative 
symptoms and cognitive deficits are increasingly prominent in the stable phase 
(Tandon et al., 2009). An accurate evaluation of neurotic behaviors is therefore 
critical for schizophrenia diagnosis, particularly at the early stage, as such 
symptoms also exist in other neuropsychiatric disorders, such as bipolar disorder 
(American Psychiatric Association DSM-5 Task Force., 2013). Some studies 
have also indicated a partial overlap in the susceptibility genes of bipolar disorder 
and schizophrenia (Berrettini, 2003; Drexhage et al., 2010; Schumacher et al., 
2004). Compared to healthy people, schizophrenia patients also have an 
increased risk for development of depression (Buckley et al., 2009). Additionally, 
the social deficit is a core symptom of other psychiatric disorders, such as autism 
spectrum disorder. However, as my thesis work did not cover early 
neurodevelopmental aspects, autism spectrum disorder is not detailed in this 
review. 
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1.1.3 Validity and limitation of modeling behaviors in mice for human 
diseases 
Three criteria are commonly used to validate a mouse model (Chadman et al., 
2009). These include construct, face, and predictive validities. Construct validity 
refers to the resemblance of an animal model to a disease in etiology and 
mechanisms. These include genetic factors such as inactivation or 
polymorphisms of gene(s) implicated in human mental disorders that are found 
in a mouse model with similar mutation(s). For example, the disrupted-in-
schizophrenia (DISC) polymorphism was first discovered in a large Scottish 
family with schizophrenia (Blackwood et al., 2001). Accordingly, a transgenic 
mouse line expressing a dominant-negative human C’-truncated DISC1 in the 
forebrain was shown to exhibit a range of anatomical and behavioral 
characteristics related to schizophrenia (Hikida et al., 2007). Other non-genetic 
approaches that can be replicated in a mouse model are also included, such as a 
neuroanatomical lesion, drug exposure, and environmental risk factors. For 
instance, injection of poly (I:C), an immunostimulant inducing viral infection, 
activates the maternal immune system in pregnant mouse mother. The offspring 
of the treated mother display behaviors such as sociability deficits and ultrasonic 
vocalization resembling autistic symptoms (Malkova et al., 2012).  
 
Face validity refers to aspects in a mouse model (mouse behavior, 
neuropathological abnormalities, and biological responses) that resemble 
symptoms in a human disease. For example, impairment in pre-pulse inhibition 
(PPI) in mice is relevant to the sensorimotor gating dysfunction of schizophrenia. 
Deficits in sensorimotor gating is diagnosed as a cognitive symptom in 
schizophrenia. (Powell and Miyakawa, 2006). PPI is a neurological phenomenon 
in which a weaker prestimulus inhibits the reaction of rodent to a subsequent 
strong startling stimulus (Caine et al., 1992).  
 
Predictive validity refers to pharmacological treatment showing similar effects in 
a mouse model as in a human disease, e.g. a specific class of drugs that improve 
symptoms in a human disease can also reverse endophenotypes in a mouse model. 
For example, benzodiazepines are anxiolytic drugs that have been traditionally 
used in the treatment of generalized anxiety disorder and major depressive 
disorder (Mitte et al., 2005). Mouse models showing behaviors of anhedonia, 
helplessness, and anxiety also display decreased anxiety in responses to 
benzodiazepine treatment (Chadman et al., 2009; Crawley et al., 1997). 
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Mouse models, in combination with other experimental approaches, elucidate the 
causative relationship of a particular genetic lesion with behavioral 
endophenotypes. Mouse models also provide an indispensable step for drug 
discovery. Nevertheless, several limitations need to be carefully considered in 
future research. The interaction between genetic and non-genetic factors is a 
critical issue that should be taken into account when studying neuropsychiatric 
mouse models. First, environmental factors such as stress and maternal immune 
activation during pre- and post-natal development can induce a large variation of 
symptoms in human diseases (Bronson and Bale, 2014; Campeau et al., 2011; 
Patterson, 2011; Reiche et al., 2004). For example, an epidemiological study 
revealed that a functional genetic polymorphism in the serotonin transporter 
promoter region significantly moderates the influence of stress on depression by 
correlation analysis. This suggests that the interaction between gene and 
environment contributes to depression disease progression (Caspi et al., 2003). 
Second, based on previous studies (Nestler and Hyman, 2010; Powell and 
Miyakawa, 2006), it seems impossible to completely model all complex human 
neuropsychiatric disorders in mouse models. Although a single candidate gene 
may cause or prevent neuropsychiatric-like symptoms in a mouse model, which 
may recapitulate a human disease (Erhardt et al., 2011; Soliman et al., 2010), it 
is still difficult to elucidate the etiological contribution of this gene to multiple 
human symptoms. Third, although behavioral tests in mouse models provide a 
better and central means to determine biological function(s) of a target gene, 
exploring sufficient mouse behavioral assays to investigate human symptoms is 
another large challenge. Several standard tests to assess locomotor activity, 
sensory processing, anxiety, and social interaction resembling human symptoms 
in neuropsychiatric disorders are summarized in Table 1. Several individual 
symptoms, such as auditory hallucinations and delusions in schizophrenia, have 
not been successfully modeled due to difficulty in finding murine correlates 
(Nestler and Hyman, 2010). Finally, individual variation in humans brings 
another challenge in accurately evaluating human diseases, when compared to 
animal models.  
 
The role of gender should be carefully considered in mice behavior and drug 
responses, as the risk for developing mood disorders is higher in women 
compared to men (Kessler, 2007; Kim et al., 2016b; Wittchen et al., 2011). The 
majority of studies have focused on males, and most mouse animal models have 
been primarily developed and validated for males (Beery and Zucker, 2011). 
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However, sex steroids exert influence on the nervous system during the critical 
developmental period and the organization of neuronal circuitry involved in 
neuroendocrine and behavioral functions (Matsumoto, 1991). It is therefore 
essential to use both sexes to study differences in behavior and drug responses in 
mouse models. For example, females of both C57BL/6J and BALB/c strains 
display more social phenotypes than males (An et al., 2011). Ketamine, a rapid-
acting antidepressant, causes sex-dependent neurochemical and behavioral 
responses in naïve and stress-exposed C57BL/6J mice (Franceschelli et al., 2015). 
Using studies of both sexes will help us observe novel finding, such as a gender 
differences in serotonergic neurochemical responses (Dalla et al., 2010). These 
studies also contribute to gender-oriented prevention, diagnosis, and treatment of 
neuropsychiatric disorders in patients (Hughes, 2007; Wald and Wu, 2010). 
Nevertheless, further effort is still needed in several areas. More powerful genetic 
methods that precisely control gene expression in spatial and temporal manners 
are required. Mouse models should be used to investigate the involvement of 
environmental, age, and gender factors in the etiology and pathophysiology of 
neuropsychiatric diseases. Finally, more powerful mouse behavioral assays 
should be used to mimic individual neuropsychiatric symptoms. 
 
 
 
Table 1. List of rodent behavioral tests relevant to symptoms in 
neuropsychiatric disorders. Modified from previous studies (Chadman et al., 
2009; Cohen et al., 2008; Henry et al., 2010; Martinowich et al., 2009; Miklowitz 
and Johnson, 2006; Powell and Miyakawa, 2006; Sokolowska and Hovatta, 2013) 
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Disorders Human 
Symptoms  
Behavior in 
mice 
Behavioral 
tests in 
mice 
Parameters 
measured 
in mice  
Generalized 
anxiety 
disorder 
 
Persistent and 
excessive worry; 
Concentration 
difficulties; 
Restlessness, 
Insomnia; Fatigue; 
Headache; Sleep 
disturbance 
Anxiety Light/dark test, 
Open-field test 
and Elevated 
plus-maze 
Light/dark: 
total travel 
distance, the 
transits 
between the 
light and dark 
compartments 
Open-field: 
total travel 
distance, the 
time spent in 
the center 
Elevated plus-
maze: total 
travel distance, 
the time spent 
in open arm 
Explorative 
and cognitive 
deficits 
Y-maze The first arm e
ntered,  
the 
amount of time
spent in 
each arm,  
total number  
of arm entries 
 
Post-
traumatic 
stress 
disorder 
 
Persistent memory of 
the traumatic events; 
Dissociation; 
Persistent negative 
trauma-related 
emotions (e.g., anger, 
guilt, shame); Limited 
work and social 
functioning 
Increased 
freezing 
response to 
fear 
conditioning 
Cue and 
contextual fear 
conditioning 
test 
The 
percentage of 
freezing time 
in the 
conditioning 
chamber 
Decreased fear 
extinction 
Fear extinction 
test 
The 
percentage of 
freezing time 
in the 
conditioning 
chamber 
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Anxiety Light/dark test, 
open-field test 
and elevated 
plus-maze 
Light/dark: 
total travel 
distance, the 
transits 
between the 
light and dark 
compartments 
Open-field: 
total travel 
distance, the 
time spent in 
the center 
Elevated plus-
maze: total 
travel distance, 
the time spent 
in open arm 
Major 
depressive 
disorder 
 
Low self-esteem; 
Feelings of 
hopelessness; 
Impaired 
concentration; Weight 
changes; Decreased 
interest in pleasurable 
stimuli 
Learned 
helplessness 
Forced 
swimming test 
Immobility 
time, the 
latency to the 
first 
immobility  
Learned 
helplessness 
Tail 
suspension test 
Immobility 
time 
Stress-induced 
anxiety 
Novelty-
induced 
hypophagia 
test 
The latency 
and time spent 
in 
consumption 
of food in a 
novel 
unfamiliar 
environment 
Anhedonia Sucrose 
consumption 
test 
Water and 
sucrose 
solution intake 
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Bipolar 
disorder 
Irritability; Euphoria; 
Insomnia; Impulsive 
behavior; Increased 
activity; Rapid 
thought processes; 
Distractibility; 
Depressive symptom 
 Hyperactivity 
and reduced 
anxiety 
Light/dark test, 
open-field test 
and elevated 
plus-maze 
Light/dark: 
total travel 
distance, the 
transits 
between the 
light and dark 
compartments 
Open-field: 
total travel 
distance, the 
time spent in 
the center 
Elevated plus-
maze: total 
travel distance, 
the time spent 
in open arm 
Anhedonia Sucrose 
consumption 
test 
Water and 
sucrose 
solution intake 
Learned 
helplessness 
Forced 
swimming test 
Immobility 
time, the 
latency to the 
first 
immobility 
Aggressive 
behaviors 
Resident-
intruder test 
The time spent 
in social 
interactive 
process  
Schizophrenia Delusion and 
hallucination; Poverty 
of speech; 
Inability to feel 
pleasure; 
Sensorimotor 
gating 
impairment 
Prepulse 
inhibition of 
startle 
response 
The startle 
amplitude on 
pre-pulse trial, 
the startle 
amplitude on 
pulse alone 
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Lack of interest 
Reduction of 
emotional expression; 
Lack of motivation; 
Cognitive deficits 
 
Social deficits Three-
compartment 
chamber social 
tests 
The time spent 
in social 
interactive 
process 
Working 
memory 
deficits 
Various maze 
tests (T-maze, 
8-arm radial 
maze, Morris 
water maze) 
T maze: total 
travel distance 
during the 
session, and 
the number of 
omission, 
correct and 
error entries 
into the arm  
8-arm radial 
maze: the 
number of first 
and repeat 
entries into 
any arm 
Morris water 
maze: the 
percentage of 
time spent in 
the right 
quadrant, 
latency to 
reach platform    
 
Increased 
locomotor 
activity 
Open-field test Total travel 
distance, the 
time spent in 
the center 
 
1.2 Inbred mouse strains 
Genetically modified mouse models include knock-out, knock-in, transgenic, or 
mutation of genes of interest. These models are broadly utilized to study 
neurobiological phenotypes under physiological and disease states. In 
neuroscience research, mouse behavioral phenotypes are essential in identifying 
the neurobiological functions of the target genes. Genetic background variations 
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of genetically modified mouse models may confound interpretation of behavior. 
Accordingly, it is necessary to investigate behavioral differences of inbred mouse 
strains. An appropriate inbred mouse strain is then chosen for genetic 
manipulation to characterize potential target genes related to mental disorders. 
Spontaneous genetic variations in inbred mouse strains impact their behavioral 
phenotypes. Inbred strains have therefore been used as a powerful tool to screen 
candidate genes and investigate these genes underlying molecular mechanisms 
(Moy et al., 2008; Powell and Miyakawa, 2006; Singer et al., 2009; Sokolowska 
and Hovatta, 2013). Behavioral differences in commonly used inbred mice, 
particularly aberrant behavior related to neuropsychiatric disorders, will be 
discussed in the following sections. 
 
1.2.1 Differences in behavioral endophenotypes among inbred mouse strains 
? Anxiety 
Anxiety disorders are affected by a combination of genetic, environmental factors, 
and stress (Hovatta and Barlow, 2008; Sokolowska and Hovatta, 2013). Since 
anxiety is a broadly conserved adaptive response to environment through 
evolution, mouse behavior can be used to study human anxiety (Nesse, 1998; 
Stein and Bouwer, 1997). Most standard laboratory anxiety tests were introduced 
in section 1.1.1.1. Comparison of different inbred strains have been broadly 
studied, but some results vary due to different laboratory environments (Crabbe 
et al., 1999; Holmes et al., 2002; Voikar et al., 2005; Wahlsten et al., 2006). In 
general, high-anxiety strains include DBA/2, 129S, A/J, and BABL/c in standard 
anxiety tests (open-field, light/dark, and elevated-plus maze) compared to low-
anxiety strains C57BL/6 and FVB/N (Crawley et al., 1997; Li et al., 2014; Voikar 
et al., 2005). Variety in anxiety-like behavior among inbred strains may be 
observed in different anxiety tests. For example, BABL/c mice spent more time 
in the open arm of the elevated-plus maze compared to DBA/2J and C57BL/6 
mice, suggesting lower anxiety in BABL/c mice (Wahlsten et al., 2006). 
However, BABL/c mice displayed more frequent transition between the light and 
dark chambers in the light/dark test compared to DBA/2J and C57BL/6 mice, 
suggesting higher anxiety in BABL/c mice (Crawley et al., 1997). C57BL/6J 
mice made significantly more transitions than either 129S6 or DBA/2J mice in 
the light/dark test, whereas 129S6 mice had significantly lower percentage of 
open entries than DBA/2J mice in the elevated-plus maze test (Holmes et al., 
2002). C57BL/6J mice spent more time in the open arm compared to DBA/2J 
and 129S2 mice in the elevated-plus maze test, but no difference was observed 
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between DBA/2J and 129S2 mice (Li et al., 2014). Additionally, C57BL/6J mice 
preferred entering into the open arm and spent more time in the open arm 
compared to DBA/2J and 129S1 mice (Moy et al., 2007). Many studies on 
anxiety-like and exploratory behaviors of mice in a new environment are 
performed by comparison between C57BL/6 and DBA/2 strains. These studies 
demonstrate that DBA/2 mice are more anxious in general (Crawley et al., 1997; 
Holmes et al., 2002; Kulesskaya et al., 2014; Voikar et al., 2005). Taken together, 
the results described above suggest that different anxiety-like behavioral tests 
cause variation in behavioral phenotypes, and more anxious mouse strains might 
serve as a mouse model to study anxiety disorder. 
 
? Social interaction and preference for social novelty 
Sociability, a major factor in the diagnosis of neuropsychiatric disorders, includes 
both social interaction and preference for social novelty. Sociability among 
inbred mouse strains has been extensively investigated in different laboratory 
environments (Brodkin et al., 2004; Kulesskaya et al., 2014; Moy et al., 2004; 
Moy et al., 2007). In general, C57BL/6 and CH3 mice are more sociable than 
DBA/2, BALB/c, BTBR, and 129S mice. For example, in the three-compartment 
social preference test, BALB/c mice spent less time with an unfamiliar mouse 
when as compared to DBA/2, FVB/N, and C57BL/6 mice (Moy et al., 2007). In 
the social interaction test, CH3 mice spent more time sniffing the intruder mice 
than BALB/c, BTBR, and 129S1 mice. In preference for social novelty, C57BL/6 
mice spent more time exploring social novelty than BALB/c, BTBR, and 129S1 
mice (Moy et al., 2004; Moy et al., 2007). Other studies demonstrated that 
BALB/c mice spent less time exploring the novel social object compared to 
C57BL/6 mice (Brodkin, 2007; Fairless et al., 2012; Sankoorikal et al., 2006). 
Smaller brain size was associated with less time in social exploration in BALB/c 
mice (Fairless et al., 2012). These results suggest that inbred mouse strains could 
serve as a mouse model to study social behavior resembling the negative 
symptom (social deficits) in schizophrenia. 
 
? Learning and memory 
Assessments of learning and memory in rodents include novel object recognition, 
fear conditioning, and Morris water maze (Holmes et al., 2002; Paul et al., 2009). 
Novel object recognition, a widely used test, in which the differences in the 
exploration time of novel and familiar objects (Ennaceur and Delacour, 1988). 
Contextual/cued fear conditioning is used to evaluate the ability of experimental 
mice to learn and remember an association between environmental cues and 
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aversive conditions (Kim et al., 2006; Paylor et al., 1994). Morris water maze 
performance reflects spatial working memory. The experimental animal is placed 
in a large circular pool, and then the mouse attempts to escape the water by uses 
various cues to find an invisible or visible platform (Upchurch and Wehner, 
1988). The fear conditioning and Morris water maze tests belong to complex 
learning tasks eliciting spontaneous learning and memory responses of rodents to 
novel stimulation or training. Several confounding factors affect the final 
evaluation of fear-conditioned auditory function in fear conditioning test and of 
the visual function in platform and probe searching in Morris water maze test. 
These factors include age- and strain-related loss or deficit in hearing (Willott et 
al., 1982; Yoshida et al., 2000; Zheng et al., 1999) and visual acuity (Wong and 
Brown, 2007; Yeritsyan et al., 2012). In general, comparisons among several 
inbred mouse strains reveal that 129S, DBA/2, and BALB/c mice display poor 
performance in the Morris water maze test compared to other strains, such as 
C57BL/6 mice (Crawley et al., 1997; Owen et al., 1997). Of note, A/J, C3H, and 
FVB mice show visual impairments and data on these strains should be 
interpreted with caution (Crawley et al., 1997; Owen et al., 1997; Upchurch and 
Wehner, 1988). In contextual fear conditioning, FVB/N, DBA/2, and C3H mice 
exhibited deficits in learning and memory compared to C57BL/6, 129S, and 
BALB/c mice (Crawley et al., 1997; Owen et al., 1997). Other behavioral tests 
among inbred C57BL/6, 129S, and DBA/2 mice demonstrated that DBA/2 and 
129S mice displayed deficits in associative and spatial learning (Holmes et al., 
2002). Additionally, C57BL/6 mice spent more time exploring the novel object 
and show a better ability of associative and spatial learning compared to DBA/2 
mice (Voikar et al., 2005). The results from these different inbred mouse strains 
provide insight for selecting an appropriate strain in transgenic mouse generation 
for specific learning and memory-related studies.       
 
? Sensorimotor gating 
Prepulse inhibition of startle response (PPI) is a traditional paradigm to study 
animal sensorimotor gating. In schizophrenia patients, sensorimotor gating is 
deficient (Caine et al., 1992; Franks et al., 1983; Singer et al., 2009). PPI is the 
suppression of a normal response to a startling stimulus when that stimulus is 
immediately preceded by a weaker pre-stimulus or pre-pulse (Graham, 1975). 
Due to different PPI responses in inbred strains, inbred strains are therefore 
broadly used to study the mechanisms of sensorimotor gating deficit in 
schizophrenia and to screen antipsychotic drugs (Hoffman et al., 1993; Humby 
et al., 1996; Olivier et al., 2001; Singer et al., 2009). Inbred mouse 129 sub-strains 
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display higher inhibition levels in PPI of both acoustic and tactile startle 
responses compared to C57BL sub-strains. In addition, DBA/2J mice have the 
poorest inhibition on startle responses compared to C57BL/6 and FVB/N mice 
(Crawley et al., 1997; Paylor and Crawley, 1997; Willott et al., 2003). Pre-
pubertal C57BL/6 mice displayed reduced startle response at the highest 
intensity and altered PPI compared to adult mice, but these effects were not 
observed in DBA/2J mice. This highlights the importance of both age and strain 
for startle plasticity during adolescence, which is a critical and sensitive period 
in the development of the majority of neuropsychiatric disorders (Pietropaolo 
and Crusio, 2009). Other studies also reveal that DBA/2 mice display more 
severe deficits in sensorimotor gating than C57BL/6 mice; these two strains are 
broadly used in drug screens and to study mechanisms of sensorimotor gating 
deficits (Bortolato et al., 2007; Bullock et al., 1997; Logue et al., 1997; Olivier 
et al., 2001; Stevens et al., 1996). 
 
Differences in behaviors of anxiety, sociability, sensorimotor gating, learning 
and memory have been compared among commonly used inbred mouse strains 
including C56BL/6J(N), FVB/N, DBA/2J, and 129S2/Sv (Figure 1.). 
 
 
Figure 1. Differences in anxiety, sociability, sensorimotor gating, learning, 
and memory behavior among four inbred mouse strains including 
C56BL/6J(N), FVB/N, DBA/2J, and 129S2/Sv. Data and conclusions were 
obtained from studies (Clawley, 1997; Willotti, 2003; Moy, 2007).  
 
1.2.2 Inbred mouse strains as animal models for neuropsychiatric disorders 
The divergence of behavioral phenotypes among inbred mouse strains can mimic 
the severity of symptoms in neuropsychiatric patients. Accordingly, inbred 
strains are useful for characterizing susceptibility genes that contribute to 
neuropsychiatric disorder progression. The benefits and limitations on using 
inbred mouse strains to study neuropsychiatric diseases are discussed here. 
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Due to the relatively stable genetic background and behavioral differences among 
inbred mouse strains, inbred strains are widely used for genome-wide mapping 
of quantitative trait loci of anxiety-like behavior and for identifying anxiety-
related susceptibility genes (Eisener-Dorman et al., 2010; Sokolowska and 
Hovatta, 2013). For example, glyoxalase 1, a detoxification enzyme converting 
cytotoxic methylglyoxal to a non-toxic form, was identified through a search for 
copy number variants in six inbred mouse strains (Hovatta et al., 2005). Inbred 
strains are also widely used to explore the novel molecular mechanisms to 
explain the inbred strains behavioral difference. For example, differences in 
hippocampal expression of α7 nicotinic acetylcholine receptor was observed in 
C57BL/6 and C3H strains. These differences modulate hippocampal long-term 
potential and auditory gating (a hippocampal-dependent behavior). The auditory 
gating is used to identify schizophrenia-associated sensory processing deficits 
(Freund et al., 2016). FVB/N, C57Bl/6J, 129S2/Sv, and BALB/c strains have 
been used to screen for proteins that mediate synaptic transmission, learning, and 
memory (Pollak et al., 2005). C57BL/6J has shown better ability in learning and 
memory compared to BALB/c, due to the attenuated corticosterone response of 
C57BL/6 (Brinks et al., 2008). These observations suggest that differences in the 
genetic background of inbred mouse strains might determine mouse behavioral 
variation. 
 
Different inbred strains are also used in antipsychotic drug screens. For example, 
C57BL/6 strain showed a stronger response to diazepam than DBA/2, A/J, and 
BALB/c strains (Crawley and Goodwin, 1980; Crawley and Davis, 1982; Mathis 
et al., 1995; Mathis et al., 1994). Sub-chronic application of oxytocin, a 
neuropeptide hormone, increased sociability and decreased repetitive behavior in 
both BALB/c and C58/J mice (Teng et al., 2013). BALB/c (Deutsch et al., 2012) 
and BTBR (Burket et al., 2013) mice have both been used to screen for drugs that 
improve mouse sociability. 
 
Although inbred mouse strains are useful for basic and translational studies, 
several limitations need to be considered. Creating an adequate animal model of 
neuropsychiatric disorder represents a challenge in inbred mouse strains, as it is 
impossible that one inbred mouse strain can fully recapitulate all symptoms in a 
neuropsychiatric disorder. Therefore, mice behavior resembling neuropsychiatric 
symptoms are usually characterized in several inbred mouse strains, such as 
DBA/2, BALB/c, and BTBR (Brodkin, 2007; McFarlane et al., 2008; Powell and 
Miyakawa, 2006; Singer et al., 2009). Although genome-wide analysis in inbred 
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mice provides genetic information on behavioral profiles, precise cellular and 
molecular mechanisms need to be further investigated in genetically modified 
mice (Sokolowska and Hovatta, 2013). Accordingly, inbred mouse strains cannot 
replace genetically modified mouse models in studying molecular mechanisms 
of neuropsychiatric disorders. Since genetically modified mouse models with 
different genetic backgrounds of inbred strains display different behavioral 
responses, the selection of genetic background in inbred strains influences 
understanding of target gene function(s) (Freund et al., 2016). Differences in 
sociability among inbred mice have been extensively studied (Moy et al., 2008; 
Moy et al., 2007). However, genetic factors modulating sociability in inbred mice 
has not been extensively studied, precluding our novel insights in social deficits 
symptom in neuropsychiatric disorders (Sankoorikal et al., 2006).   
 
1.3 Roles of the innate immune system in brain and behavior 
Increasing evidence suggests that immune system malfunction is involved in the 
progression of complex neuropsychiatric diseases (Carter et al., 2014; Drexhage 
et al., 2011b; Onore et al., 2012; Sekar et al., 2016). Interactions between the 
CNS and the immune system occur in both healthy and diseased states. 
 
As mentioned above, genetic factors often need to be placed in the context of the 
environment, as both genetic and environmental factors jointly determine the 
progression of multiple mental disorders. Both epidemiological and animal 
studies reveal that maternal immune activation (MIA) increases the risk of autism 
spectrum disorder and schizophrenia in the offspring (Patterson, 2009). For 
example, maternal immune activation was shown to induce maternal pro-
inflammatory cytokines such as IL-1β, TNF-α, and IL-6. These cytokines 
invaded into the fetal CNS to induce neuroinflammation and schizophrenic and 
autistic phenotypes in the offspring (Brown, 2012; Horvath and Mirnics, 2014; 
Hsiao et al., 2012; Onore et al., 2012). MIA also increased depressive behavior 
in murine offspring (Enayati et al., 2012). Although elevated levels of cytokines 
TNF-α and IL-6 are associated with both psychosocial stress and depressive 
symptoms in pregnant mothers (Christian et al., 2009), no direct association 
between prenatal viral infection and nonpsychotic depression were observed later 
in the life of the offspring (Pang et al., 2009). Additionally, exposure to repeated 
psychosocial stress caused microglial activation and recruitment of peripheral 
monocytes into the brain, contributing to the development of anxiety-like 
behaviors in mice (Wohleb et al., 2013). Increased microglial activation and 
macrophage recruitment are associated with major depressive disorder in humans 
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(Setiawan et al., 2015; Steiner et al., 2011; Torres-Platas et al., 2014). These 
observations suggest that brain immune system activation modulates immune 
cells in the brain to produce cytokines that contribute to behavioral changes and 
the pathogenesis of neuropsychiatric diseases. 
 
The following sections focus on summarizing the major innate immune 
components in the brain and their roles in mental disorders. Adaptive immune 
cells, such as T cells, also contribute to cognitive functions (Luz Correa et al., 
2014; Radjavi et al., 2014). For example, interferon-gamma (IFN-γ) derived from 
meningeal T cells directly drove GABAergic inhibitory tone in the prefrontal 
cortex (PFC). A strong interaction between social behavior and IFN-γ-driven 
immune responses was further observed in rodent brain and cellular 
transcriptomes, suggesting that IFN-γ modulates neural circuits recruited for 
social behavior (Filiano et al., 2016). For the sake of brevity, neurobiological 
functions of adaptive immune cells will not be elaborated here. 
 
1.3.1 Peripheral innate immune components in the brain: monocytes and 
macrophages  
The innate immune response is the first line of defense against pathogens and 
further provides fundamental signaling to initiate an adaptive response. Upon 
encountering peripheral infectious stimuli (bacterial, viral, or fungal), innate 
immune cells immediately infiltrate to the site of infection. These cells also clear 
invading pathogens and dead cells and produce cytokines that further recruit 
innate and adaptive immune cells. Activated adaptive immune cells, in turn, 
mediate the regulation of innate immune cells and the formation of 
immunological memory (Medzhitov and Janeway, 1998; Mogensen, 2009). 
 
The CNS is immune-privileged due to the blood-brain barrier (BBB) and other 
mechanisms (Bechmann et al., 2007; Kwidzinski et al., 2003). The CNS 
nevertheless sustains constant immune surveillance in the brain (Ransohoff and 
Engelhardt, 2012; Shechter et al., 2013a), although the mechanisms of immune 
cell trafficking to the CNS are poorly understood. CNS-derived soluble antigens 
in the interstitial fluid drain into the cerebrospinal fluid by perivascular channels, 
and are then detected by meningeal innate cells, macrophages, and other APCs 
in the subarachnoid space. Furthermore, these antigens are transported to the 
nasal mucosa, and then delivered into deep cervical lymph nodes by afferent 
lymphatics (Engelhardt and Ransohoff, 2005; Goldmann et al., 2006; Weller et 
al., 1996). Recent discoveries on the lymphatic system may elucidate the etiology 
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of neuroinflammation in mental diseases. Lymphatic vessels lining the dural 
sinuses are connected to deep cervical lymph nodes and can carry both fluid and 
immune cells from the cerebrospinal fluid (Aspelund et al., 2015; Louveau et al., 
2015). This discovery represents a novel pathway for cerebrospinal fluid drainage 
and a more conventional pathway for immune cells infiltration into the CNS, 
suggesting that the current dogmas regarding brain tolerance and immune 
privilege should be reconsidered. 
   
? Monocytes 
Monocytes are myeloid cells that reside in the spleen and blood. They are 
produced from bone marrow hematopoietic stem cells. In the CNS, myeloid cell 
populations (except microglia) are maintained by replacement from blood 
monocytes. Although monocytes do not consistently traffic to the CNS to 
contribute to the microglia pool (Ajami et al., 2011), monocytes can play 
important roles in modulating neuroinflammation and anxiety-like behavior in 
rodents. For example, infiltrating monocytes in injured spinal cords caused an 
inflammatory response (Kigerl et al., 2009). Repeated social stress induced 
monocyte recruitment into the brain, and microglial production of 
proinflammatory cytokines promoted anxiety-like behavior in mice (Wohleb et 
al., 2013). In humans, circulating monocytes and proinflammatory cytokines (IL-
1β, IL-6 and TNF-α) are increased in depression patients (Hannestad et al., 2011; 
Howren et al., 2009; Maes et al., 1992). The peripheral immune change is linked 
to increased macrophages and microglia in depression patients (Setiawan et al., 
2015; Steiner et al., 2011; Torres-Platas et al., 2014). Additionally, circulating 
monocytes display a proinflammatory status in bipolar disorder patients 
(Drexhage et al., 2011a). Dynamic changes of inflammatory gene expression in 
monocytes were observed in the offspring of bipolar patients from adolescence 
into adulthood (Mesman et al., 2015). These discoveries revealed that monocytes 
in the brain or periphery induce an inflammatory response and cytokine 
production under stress or infection conditions in rodents and humans. 
Accordingly, these cytokines might contribute to the pathogenesis of 
neuropsychiatric diseases. 
 
? Macrophages 
Brain macrophages are derived from monocytes and localize in the perivascular 
space, choroid plexus, and meninges of the brain. They play an important role in 
antigen presentation in the interstitial fluid, propagating cytokine signaling, and 
modulating the inflammatory response in vascular endothelial cells (Serrats et al., 
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2010). Meningeal macrophages enrich myelin antigens and present them to 
microglia for ingestion (Fitzner et al., 2011). Additionally, monocyte-derived 
macrophages migrate into injured spinal cords via modulating epithelial cells 
(Shechter et al., 2013b). Systemic LPS challenge in mouse increases 
inflammatory macrophages in the CNS and prolongs the so-called “sickness 
behavior” (decreased motor activity, reduced food and water intake, and 
increased sleep) and social withdrawal (Dantzer et al., 2008; Wohleb et al., 2012). 
During systemic infection, cytokines such as IL-1β, IL-6, and TNF-α produced 
by peripheral macrophages and other immune cells can perfuse into certain brain 
regions which lack a normal BBB, such as the circumventricular organs of 
hypothalamus. These cytokines can directly activate neurons and recruit local 
microglia to initiate and maintain the sickness behavior, which shares immune-
related mechanisms with depression (Dantzer et al., 2008). Similar to monocytes 
in the brain, these observations suggest that macrophages in the CNS and 
periphery play important roles in cytokine production, neuroinflammation, and 
behavioral changes in rodents and humans. 
 
1.3.2 Microglia 
Microglia are the resident innate immune phagocytes in the brain. They survey 
the local microenvironment, interact with other glial cells and neurons to aid 
structural elimination and formation of synapses, and regulate functional synaptic 
maturation and plasticity in developing and mature brains (Frost and Schafer, 
2016; Nimmerjahn et al., 2005; Tremblay et al., 2010). However, under 
neuroinflammatory conditions, microglial activation contributes to synaptic loss 
and disrupts circuit connectivity of neuronal networks. Although current studies 
have partially elucidated the roles of microglia in the pathogenesis of 
neuropsychiatric disorders, further investigation is still necessary (Beggs and 
Salter, 2016; Chung et al., 2015). 
 
1.3.2.1 Ontogenesis of microglia 
Microglia were first distinguished from other glial cells (such as astrocytes and 
oligodendrocytes) by del Rio-Hortega, who also suggested the embryonic origin 
of microglia (Tremblay et al., 2015). During the past several decades, many 
hypotheses existed regarding the origin of microglial progenitors and microglial 
development at early embryonic and post-natal developmental stages, as well as 
microglial maintenance during adulthood (Ajami et al., 2007; Lawson et al., 1992; 
Ling, 1979; Mildner et al., 2007). Although several studies have suggested the 
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yolk sac origin of microglia (Alliot et al., 1999; Cuadros et al., 1993; Herbomel 
et al., 1999), Ginhoux et al. provided the first direct in vivo evidence 
demonstrating that microglia arose from yolk sac primitive macrophages on 
embryonic day 8.5, which then migrated through blood vessels into the 
embryonic brain (Ginhoux et al., 2010) (Figure 2A). 
 
Although cytokine macrophage-colony stimulating factor is indispensable for the 
development of tissue resident macrophages, it is not necessary for microglial 
development. Microglia are extremely dependent on the CSF-1R during their 
development, as Csf-1R-/- mice were found to be devoid of microglia in the brain, 
suggesting that an alternative ligand for CSF-1R is essential for microglial 
homeostasis (Ginhoux et al., 2010) (Figure 2A). Another cytokine ligand for 
CSF-1R (Lin et al., 2008), IL-34, was also found to be involved, as IL-34-
deficient mice showed significantly fewer microglia (Wang et al., 2013). Under 
inflammatory conditions, C-C chemokine receptor type 2 is essential for 
circulating monocyte migration through the blood vessels into the brain. These 
monocytes then give rise to the transient microglia-like cells (Mildner et al., 
2007). Alternatively, short-term hematopoietic stem cells can directly 
differentiate into long-lived microglia-like cells under such conditions (Ajami et 
al., 2007; Greter and Merad, 2013). 
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Figure 2. Immune genes play multiple roles in neural development. Microglia, 
astrocytes, and neurons share a common molecular language within the CNS, and 
continually communicate via cytokines, chemokines, neurotransmitters, and 
other factors (center circle). Many of the same molecules originally identified for 
their roles in immune function have now been implicated in neural development. 
(A) Cytokines such as IL-1β and IL-6 play a role in cytogenesis within the 
developing brain. Macrophage-colony stimulating factor and the CSF-1 receptor 
are important for microglial recruitment into the CNS. (B) CXCL12 and its 
receptor CXCR4 guide the migration of new neurons in many brain regions. This 
chemotaxis also guides microglia recruitment into the neuronal germinal niches 
to help neuronal progenitor cell differentiation. (C) MHCI is critical for the 
activity-dependent formation of synapses within the visual cortex. TNF-α 
released by astrocytes promotes synaptic transmission and affects activity-
dependent synaptic scaling. (D) Complement proteins C4, C1q, and C3 tag 
synapses for elimination by activation of the complement cascade. Complement 
cascade is a biochemical pathway that involves interactions of various 
complement proteins in a specific sequence, leading to inflammation. Microglia 
recognize these proteins via the complement receptor 3 (CD11b), and 
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phagocytose the labeled synapses as a mechanism of synaptic pruning. (E) The 
phagocytic function of microglia plays an important role in cleaning cell debris 
during brain development and inflammation. Modified from (Bilbo and Schwarz, 
2012). Figure 2 was reprinted with permission from Elsevier. Copyright © 2012 
Elsevier Inc. Permission was conveyed through Copyright Clearance Center, Inc. 
 
1.3.2.2 Polarization of microglia 
Microglial polarization indicates microglial adaptation to CNS remodeling from 
various stimuli. In the inflammatory state, microglia display dual roles. On one 
hand, they execute neuroprotective functions by inhibiting local inflammation 
and cleaning cell debris to promote brain recovery (Hanisch and Kettenmann, 
2007; Miron et al., 2013). On the other hand, they also induce inflammation and 
impair neuronal activities (Ekdahl et al., 2003; Liu et al., 2007). 
 
Like macrophages, microglia are differentiated into classically activated M1-
microglia and alternatively activated M2-microglia. Differentiation occurs in in 
vitro culture medium with polarizing T helper cell-derived cytokines, IFN? (for 
M1) and IL-4 or IL-13 (for M2). The M1/M2 classification of microglia is often 
used in research, but the classification has limitations in reflecting microglial 
phenotypes in vivo and is currently debated (Chiu et al., 2013; Hickman et al., 
2013; Kan et al., 2015; Ransohoff, 2016; Zhang et al., 2014b). One limitation is 
that such classification only represents two extreme states of microglia (Gaikwad 
and Heneka, 2013) and may not recapitulate the versatile functions of microglia 
in vivo. Increasing evidence suggests that microglial activation is finely tuned 
and microglial cells may rather adopt various intermediate phenotypes depending 
on the context and the stimuli (Franco and Fernandez-Suarez, 2015). However, 
due to the lack of adequate tools to categorize microglial functions, the literature 
has opted to use M1 and M2 as the basic classification of microglial functions. 
 
M1-microglia produce pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), 
MHCI, reactive oxygen species, and nitric oxide, which induce a 
proinflammatory status and contribute to neuronal dysfunction in the brain 
(Kettenmann et al., 2011). M2-microglia are characterized by expression of 
arginase-1 (Arg-1), mannose receptor C type 1, transforming growth factor-beta 
(TGF-β), anti-inflammatory cytokine IL-10, and chitinase 3-like 3 (Chi3l3) 
(Kawahara et al., 2012). M2-microglia restore immune homeostasis by 
dampening cerebral inflammation, increasing phagocytosis, angiogenesis, axonal 
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remodeling, and brain repair (Hu et al., 2015; Saijo and Glass, 2011). The 
phagocytic function of microglia plays an important role in cleaning cell debris 
during brain development and inflammation (Figure 2E). 
  
1.3.2.3 Physiological functions of microglia 
Emerging evidence suggests that microglia play a crucial role in surveying and 
maintaining the neuronal connectivity in healthy brain development (Graeber, 
2010; Monier et al., 2006; Paolicelli et al., 2011; Stevens et al., 2007). 
Elimination of apoptotic neurons without inflammation is crucial for brain tissue 
homeostasis. A better understanding of normal microglial functions in the healthy 
brain may elucidate the microglial contribution to the pathogenesis of mental 
disorders.  
 
In the healthy brain, microglia acquire ramified morphology. Although the 
ramified microglia are called “resting” microglia, they keep moving at a speed of 
1μm/min in the adult mouse brain to continuously scan their surroundings 
(Nimmerjahn et al., 2005). Such mobility of microglia promotes their transient 
contact with astrocytes, axon terminals, and dendritic spines. This mobility also 
allows microglia to rapidly initiate responses to extracellular stimuli, as observed 
with in vivo two-photon laser-scanning microscopy (Davalos et al., 2005; Wake 
et al., 2009). Regarding regulatory factors for mobility, a recent study showed 
that ionotropic glutamatergic and GABAergic neurotransmission-mediated 
neuronal activity regulated microglial morphology and mobility in different 
manners. Microglial mobility was increased by ionotropic glutamatergic 
neurotransmission, but was decreased by ionotropic GABAergic 
neurotransmission, suggesting neurotransmission plays a role in regulating 
“resting” microglial behavior (Fontainhas et al., 2011). 
   
During early brain development, microglia are involved in neurogenesis (Aarum 
et al., 2003; Arno et al., 2014; Cunningham et al., 2013) and neuronal positioning 
in the cerebral cortex (Arno et al., 2014). In later developmental stages and in 
adulthood, microglia actively contact pre- and post-synaptic elements. Microglia 
have also been demonstrated to prune synapses in various brain areas, such as the 
hippocampus, the thalamic retino-geniculate system, and the visual cortex 
(Paolicelli et al., 2011; Stevens et al., 2007; Tremblay et al., 2010). The precise 
mechanisms of synaptic pruning mediated by microglial molecules will be 
discussed in section 1.3.4. 
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1.3.2.4 Pathophysiological functions of microglia in neuropsychiatric 
disorders 
Microglia have been extensively studied in the context of CNS 
neuroinflammation, when the brain is challenged by various stimuli such as stress, 
infection, and injury. Complex interactions between the immune system and the 
brain are implicated in the etiology of neuropsychiatric disorders. In addition to 
neuronal molecules, multiple microglial factors such as cytokines, chemokines, 
complete components, and MHC molecules may contribute to the pathogenesis 
of these diseases (Bilbo and Schwarz, 2012; Dantzer et al., 2008; Malkova et al., 
2012; Na et al., 2014). 
 
Accumulating evidence suggests that immune activation is strongly associated 
with schizophrenia, bipolar disorder, or autism (Beumer et al., 2012; Brown, 
2012; Horvath and Mirnics, 2014; Hsiao et al., 2012; Patterson, 2011). Brain 
tissue transcriptomic profiles of autism patients suggest an association of 
synaptic dysfunction and microglial or immune dysregulation with autism 
progression (Voineagu et al., 2011). Activated microglia and increased 
microglial density were observed in brain specimens from autism (Morgan et al., 
2010), schizophrenia (Bloomfield et al., 2016; van Berckel et al., 2008), and 
bipolar disorder patients (Haarman et al., 2014). Recent work on CX3C 
chemokine receptor 1 (CX3CR1)-knockout (KO) mice has demonstrated the 
pivotal roles of microglia in social behavior (Zhan et al., 2014). Another study 
reported that impaired autophagy in microglia due to autophagy-related gene 
Atg-7-deficiency led to social behavioral deficits, suggesting the involvement of 
microglia in the pathogenesis of autism (Kim et al., 2016a). 
 
Activation of the human innate immune system increases the morbidity of 
depression. In healthy humans, endotoxin administration, such as interferon-
alpha (IFN-α) treatment and typhoid vaccine administration, results in the 
occurrence of depression-like symptoms (DellaGioia and Hannestad, 2010). 
About 50% of patients with chronic hepatitis C infection, who were systemically 
treated with the immune-activating agent IFN-α, developed depressive symptoms 
over the course of 2-3 months, which was managed by antidepressants (Capuron 
and Miller, 2004; Lotrich et al., 2009). Several clinical studies provided direct 
evidence on the association of activated microglia with depression or depression-
related suicide (Bayer et al., 1999; Steiner et al., 2011; Torres-Platas et al., 2014). 
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1.3.3 Stress and immunity 
The development and exacerbation of affective disorders such as depression and 
anxiety are associated with exposure to repeated psychological stress and 
alteration of immune function (Wohleb and Delpech, 2016). A direct relationship 
of social stress with reactivation of latent herpes simplex virus (HSV) was 
reported (Padgett et al., 1998b). Chronic stress is associated with wound healing, 
aging, and cancer through immune modulation (Kiecolt-Glaser et al., 2003; 
Padgett et al., 1998a; Powell et al., 2013b; Reiche et al., 2004). Psychological 
stress perceived by our brain affects the CNS, the endocrine, and the immune 
systems. Stress regulates the peripheral immune system by interaction with two 
other systems, mainly the hypothalamus-pituitary-adrenal gland (HPA) 
neuroendocrine system and the autonomic nervous system, including the 
sympathetic nervous system (SNS) and parasympathetic nervous system (PSNS) 
(Glaser and Kiecolt-Glaser, 2005). 
 
Glucocorticoids released from the adrenal gland modulate functions of various 
immune cells. Glucocorticoids inhibit the expression of pro-inflammatory genes 
and promote the expression of anti-inflammatory genes (Rhen and Cidlowski, 
2005). Stress-induced glucocorticoids influence cognitive processing by 
modulating changes in brain glutamate neurotransmission (Popoli et al., 2012). 
The autonomic nervous system has multiple immune regulatory functions. The 
PSNS, namely the vagus nerve, is controlled by the brain network. The 
neurotransmitter acetylcholine released from the vagus nerve binds to 
acetylcholine receptors on the surface of macrophages to initiate the intracellular 
signal (Wang et al., 2003). The activated intracellular signal then inhibits 
cytokine production, suggesting that PSNS constitutes an anti-inflammatory 
reflex circuit during infection (Rosas-Ballina et al., 2008; Tracey, 2007). 
However, the involvement of the PSNS in psychosocial stress-induced immune 
functions is currently less clear. Stress is known to activate the SNS, which 
innervates the immune organs and regulates immune response through released 
catecholamines (such as noradrenaline and adrenaline) (Bellinger and Lorton, 
2014; Irwin and Cole, 2011). The SNS regulates humoral and cellular immune 
responses (Bellinger and Lorton, 2014; Scanzano and Cosentino, 2015), 
leukocyte trafficking (Heidt et al., 2014; Pongratz and Straub, 2013; Powell et al., 
2013a), and hematopoiesis (Lucas et al., 2013; Mendez-Ferrer et al., 2008; 
Powell et al., 2013a). 
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1.3.3.1 Stress and peripheral innate immunity 
Stress-induced immune cell dysfunction, especially in innate immune cells, has 
been demonstrated to contribute to inflammation in the periphery. 
Glucocorticoids and its receptors suppress transcription factors of pro-
inflammatory genes (such as NF-κB and AP-1) and activate their inhibitors (such 
as IκBα) (De Bosscher et al., 2003; McKay and Cidlowski, 1999). Recent studies 
revealed that chronic stress increased monocytic production of cytokines (Engler 
et al., 2004; Wohleb et al., 2011), which induced glucocorticoid receptor 
desensitization (Pace et al., 2007). A similar phenomenon was also observed in 
monocytes from stressed humans (Miller et al., 2008). Repeated stress impaired 
transcription of glucocorticoid response genes and increased proinflammatory 
gene transcription in leukocytes (Cole et al., 2007). Engagement of α- and β-
adrenergic receptors on the surface of innate immune cells under stress regulates 
their specific cellular functions (Scanzano and Cosentino, 2015). For example, 
repeated social stress induced monocytes to produce proinflammatory 
components via β2-adrenergic signaling (Powell et al., 2013a). Chronic variable 
stress induced activation of the β3-adrenergic receptors to promote 
hematopoiesis, leading to an increased output of neutrophils and monocytes 
(Heidt et al., 2014). Repeated social stress promoted macrophage trafficking into 
the brain and enhanced microglial activation (Wohleb et al., 2011), and also 
exacerbated anxiety-like behavior in mice via recruitment of bone marrow-
derived monocytes into the brain (Wohleb et al., 2013). Follow-up studies 
revealed that recurrent repeated social stress prolonged anxiety-like behavior via 
monocytes that migrated from the spleen to the brain (Wohleb et al., 2014a). 
Furthermore, IL-1 signaling in endothelial cells potentiated repeated social 
stress-induced proinflammatory cytokine production, facilitating macrophage 
recruitment and microglia activation in the brain (Wohleb et al., 2014b). These 
studies suggest that psychological stress activates the endocrine and autonomic 
nervous systems to modulate innate immune cell trafficking, peripheral 
inflammation responses, and cytokine production. 
 
1.3.3.2 Stress and microglia 
Microglia actively respond to psychosocial stress and change their morphology 
and function to adapt to the surrounding microenvironment (Walker et al., 2013). 
Microglial activation has been implicated in mental disorders, as discussed in 
section 1.3.2.4. As a potential effector of microglial activation, stress may utilize 
activated microglia to exacerbate mental illness.  
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To study the effects of stress on microglial functions, several psychosocial stress 
models in rodents have been utilized. These include acute/chronic restraint, social 
isolation, stress repeated social defeat, foot shock, and tail suspension. 
Upregulation of microglial MHCII, Il1b, or Cd14 and downregulation of Cd200r 
were found in acute stress induced by tail- or foot-shock (Blandino et al., 2009; 
Frank et al., 2007). Chronic stress models demonstrated that microglial activity 
was associated with the behaviors of anxiety, social deficiency, and anhedonia 
(Couch et al., 2013; Wohleb et al., 2012; Wohleb et al., 2011). Chronic restraint 
stress caused increases of the ionized calcium-binding adapter molecule 1, 
MHCII, CD68 (antigen presentation), and caspase-3 (apoptosis) in the PFC of 
rats. Minocycline, an antibiotic inhibiting microglial activation, ameliorated the 
impact of chronic stress on working memory (Hinwood et al., 2012). These 
studies demonstrated that stress models induce microglial activation, and 
microglia activity could modulate animal behaviors such as anxiety and memory.  
 
Chronic restraint stress has been shown to increase ramification of microglia 
(Hinwood et al., 2013). Hyper-ramification of microglia was also recently found 
in mice after repetitive swim stress (Hellwig et al., 2016). In contrast, chronic 
unpredictable stress was shown to induce an initial increase of soma area and 
reduced processes length of microglia, and a later hippocampal microglial 
dystrophic morphology (Kreisel et al., 2014). Similarly, repeated social defeat-
induced stress also de-ramified microglia in the amygdala, hippocampus, and 
PFC (Wohleb et al., 2014a). These observations suggest that microglia 
dynamically change their morphologies in response to stress. 
 
Stress induces pro-inflammatory cytokine production in rodent brains (Blandino 
et al., 2009; Nguyen et al., 1998; Wohleb et al., 2011). Proinflammatory 
cytokines Il1b and particularly Tnf were upregulated in the brain at an early stage 
(within 12 hours) of repeated social defeat stress, while Il6 was only upregulated 
after 8 days of stress. Genes such as Cd14 and Cx3cr1 in the brain were 
upregulated throughout the 24 days of stress (McKim et al., 2016; Wohleb et al., 
2011; Wohleb et al., 2014a). The effects described above were due to sympathetic 
activation, as blocking sympathetic activity by the propranolol (a β-adrenergic 
antagonist) and guanethidine (an antihypertensive drug that reduce the release of 
catecholamine) counteracted the stress-induced upregulation of proinflammatory 
cytokines such as Il1b in the brain (Blandino et al., 2009; McKim et al., 2016). 
The β-adrenergic agonist isoproterenol amplified the stress effect (Johnson et al., 
2013), suggesting that activation of the sympathetic nervous system mediated by 
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stress modulates microglial activation to produce cytokines in the brain. In 
another study on chronic stress, depression-susceptible C57BL/6J mice showed 
elevated expression of TNF-α in the PFC and indoleamine-2,3-dioxygenase in 
the raphe nucleus, accompanied by increased numbers of prefrontal microglia 
compared to resilient animals (Couch et al., 2013). Conversely, the release of 
hippocampal IL-1β and TNF-α induced by acute restraint stress was completely 
blocked by an intrinsic ion channel receptor P2X7R antagonist and in Nlrp3 (a 
component of the inflammasome)-null mice. Moreover, a P2X7R antagonist 
reversed anhedonic and anxiety-like behavior caused by chronic unpredictable 
stress (Masuch et al., 2016), suggesting that stress-induced cytokine production 
contributes to depressive and anxiety-like behavior in mice.  
 
Prior exposure to a stressor sensitized LPS-induced cytokine production and 
microglial activation (de Pablos et al., 2014; Frank et al., 2007; Johnson et al., 
2013; Wohleb et al., 2012). A combination of immune challenge with 
psychosocial stressors exaggerates anxiety and social deficits in animals (Bilbo 
and Schwarz, 2012; Giovanoli et al., 2013; Wohleb et al., 2012). Circulating LPS 
can bind to Toll-like receptor 4 and its co-receptor CD14 in the circumventricular 
organs, the choroid plexus, and the leptomeninges in the brain, initiating 
downstream signaling pathways (Lacroix et al., 1998). LPS or cytokines 
administrated into the animal brain or intraperitoneal cavity upregulated 
microglial markers and increases microglial activity (Dantzer et al., 2008; Rivest, 
2009; Saijo and Glass, 2011). Acute systemic injection of LPS in rodents 
(intraperitoneally 1 mg/kg) resulted in a robust induction of pro-inflammatory 
cytokines and chemokines in microglia (Laye et al., 1994; Quan et al., 1999). 
LPS directly injected into the brain also activates Toll-like receptor 4 signaling 
to mediate cytokine and chemokine expression primarily in microglia (Glezer et 
al., 2003; Zhou et al., 2006). These observations suggest that acute stress such as 
LPS challenge in the brain or periphery induces microglial activation and 
cytokine production in the brain. 
 
1.3.4 Microglia-enriched genes in the brain and their functions 
Microglia exert unique functions in the CNS compared to other brain cells and 
their peripheral myeloid counterparts. Several studies reveal that microglia 
express unique transcriptomic profiles that are clearly distinct from other cell 
types in the brain (Beutner et al., 2013; Butovsky et al., 2014; Zhang et al., 2014b), 
suggesting microglial features in development and biological function. 
Additionally, microglial gene expression signatures display distinct region-, age- 
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and disease-dependent patterns (Chiu et al., 2013; Grabert et al., 2016; Hickman 
et al., 2013; Ma et al., 2015a; Ma et al., 2015b). For example, proteomic and 
genetic comparisons between microglia and splenic monocytes identified a 
unique microglial gene expression signature (Butovsky et al., 2014). Furthermore, 
eight inflammation-related genes were uniquely enriched in human or murine 
microglia, including Fcrls, P2ry12, Tmem119, Olfml3, Hexb, Tgfbr1, Gpr34, and 
Sall1. However, this enrichment was not detected in other immune cells, glial 
cells, or neurons (Butovsky et al., 2014). Another study also reported the same 
unique microglial genes compared to macrophages (Hickman et al., 2013). In 
transcriptome comparisons of neurons, glial cells, and endothelial cells, both the 
well-known Tnf and C1qa genes and a novel gene Rcsd1 involved in a pyridoxal 
5’-phosphate salvage pathway were identified (Zhang et al., 2014b).  
 
Comparing microglial gene expression signatures between young and aged mice, 
Hickman et al. identified a unique cluster of transcripts that encodes proteins for 
sensing endogenous ligands and microbes in healthy adult murine microglia. In 
aged mice, these genes were downregulated, including Trem2 (sensing apoptotic 
neurons), Siglech and Dap12 (neuronal injury-related molecules), and Ccr5 
(Hickman et al., 2013). Gene profiles in aged murine microglia in different brain 
regions was recently identified in another study, in particular the interferon 
pathway-related genes (Grabert et al., 2016). Microglial signature genes are also 
regionally heterogeneous. Significant differences in the gene expression profile 
involved in immunoregulatory and metabolic processes were identified among 
cortical, striatal, hippocampal, and cerebellar microglia. In particular, cerebellar 
and hippocampal microglia exist in a more immune-alert state (Grabert et al., 
2016). Taken together, microglia-enriched genes participate in various cellular 
pathways to contribute to brain development and the pathogenesis of mental 
illness. The precise functions of microglia-enriched genes will be discussed 
below. 
 
1.3.4.1 CX3C chemokine receptor 1 (CX3CR1) and CX3C chemokine 
ligand 1 (CX3CL1) 
Chemokine fractalkine (CX3CL1) protein is composed of an extracellular N-
terminal domain, a mucin-like stalk, a transmembrane α helix, and a short 
cytoplasmic tail (Bazan et al., 1997). CX3CR1, the receptor of CX3CL1, is a 
conventional Gαi-coupled seven-transmembrane receptor and surface marker on 
monocytes and lymphocytes (Wolf et al., 2013). Once CX3CL1 binds to 
CX3CR1, the G protein signaling pathway is activated to mediate leukocyte 
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migration and adhesion (Imai et al., 1997). CX3CR1 enriched in microglia 
interacts with CX3CL1 expressed in neurons to modulate neuron-microglia 
communication in the brain (Harrison et al., 1998). Reporter mice expressing 
microglia-specific fluorescent proteins are generated mostly via the CX3CR1 
promoter and have been used to study microglia-neuron interactions in the brain 
(Jung et al., 2000). Studies utilizing CX3CR1-KO mice have produced valuable 
insights on microglial functions. In healthy brain development, CX3CL1 from 
neurons initiates chemotaxis of microglia (Harrison et al., 1998). A further study 
revealed that developmental synaptic pruning and maturation mediated by 
microglia is dependent on CX3CR1, and fewer microglia were observed in 
CX3CR1-KO mice (Paolicelli et al., 2011). Additionally, CX3CR1-KO mice 
show impaired thalamo-cortical synapses in the barrel cortex due to delayed 
recruitment of microglia (Hoshiko et al., 2012). CX3CR1-KO mice also exhibit 
excessive microglial IL-1β secretion and attenuated long-term potentiation (LTP), 
resulting in impaired cognitive functions (Rogers et al., 2011). CX3CR1-KO 
mice have been shown to display a transient reduction of microglia during the 
early postnatal period and deficiency in synaptic pruning. This led to decreased 
synaptic transmission and functional brain connectivity, causing impaired social 
interaction and increased repetitive behavior in KO mice (Zhan et al., 2014). 
 
CX3CR1 may also regulate neuroinflammatory and neurodegenerative diseases 
such as Alzheimer's disease (AD). In an AD mouse model, CX3CR1-deficiency 
prevented neuronal loss due to reduced microglial number and activity 
(Fuhrmann et al., 2010), and showed reduced amyloid-beta (Aβ) deposition due 
to increased uptake of Aβ fibrils by microglia (Lee et al., 2010). Another study 
showed that CX3CR1 deficiency promoted microtubule-associated protein tau 
aggregation due to microglial activation, suggesting a beneficial role of CX3CR1 
in the AD mouse model (Bhaskar et al., 2010). Evidence suggests that neuronal 
CX3CL1 acts as a critical signal protein to maintain microglia in a quiescent 
status and prevent hyper- or hypo-activated microglia in both homeostatic and 
pathological settings (Wolf et al., 2013). 
 
The aforementioned observations suggest that CX3CR1 participates in the 
regulation of the synaptic pruning and maturation, and subsequently modulate 
neuronal activity and brain connectivity. CX3CR1 deficiency causes microglial 
dysfunction, leading to impaired cognition and sociability in mice and the 
pathogenesis of mouse models of neuroinflammation and neurodegenerative 
disease.  
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1.3.4.2 Colony stimulating factor 1 (CSF-1) and Colony stimulating factor 
1 receptor (CSF-1R) 
CSF-1 is essential for microglial ontogenesis and homeostasis (Chitu et al., 2016). 
The CSF-1R-CSF-1/IL-34 axis is important for mouse microglial development 
and steady-state maintenance in adult mice (Ginhoux et al., 2010), and is 
involved in microglial migration and phagocytosis (Lelli et al., 2013; Sasaki et 
al., 2000). Microglial recruitment into the brain germinal niches is regulated by 
CXCL12 and microglial CSF-1R (Arno et al., 2014), and microglial CSF-1 
regulates differentiation of neural progenitor cells (Nandi et al., 2012). These 
studies suggest that CSF-1R plays essential roles in microglial ontogenesis and 
migration, and facilitate neuronal progenitor cell differentiation during brain 
development (Figure 2B). 
 
1.3.4.3 Complement receptor 3 (CR3) 
CR3 is a β2 integrin (CD11b/CD18) molecule abundantly expressed by 
monocytes and neutrophils (Bhat et al., 1999; Yakubenko et al., 2002). CR3 
expressed in microglia interacts with its ligand, complement protein C3. 
Complement is localized to synapse to mediate synaptic pruning during early 
postnatal retinal development (Schafer et al., 2012). Complement C1q initiates 
complement cascade signaling to activate the downstream C3 to trigger synaptic 
elimination during retinal development (Stevens et al., 2007). C3 deposits onto 
synapses, then binds to CR3 to initiate synaptic elimination by microglial 
phagocytosis. Microglia-mediated engulfment and signaling is dependent on 
neural activity (Figure 2D) (Schafer et al., 2012; Stevens et al., 2007). TGF-β, an 
anti-inflammatory factor involved in multiple immune responses, regulates 
neuronal C1q expression and synaptic pruning in the retino-geniculate system. 
Mice deficient in TGF-β receptor II have reduced C1q expression in retinal 
ganglionic cells and decreased microglia-mediated synaptic pruning (Bialas and 
Stevens, 2013). Of note, the microglial CR3 dysfunction induces pathogenesis of 
brain diseases. For example, aberrant CR3-dependent signaling in microglia 
contributes to a synaptic loss in Alzheimer's disease (Hong et al., 2016). A study 
revealed that complement protein C4 promotes covalent C3 attachment to 
synapses, leading to synaptic elimination (Figure 2D). The C4 allele is associated 
with the risk of schizophrenia progression (Sekar et al., 2016). Additionally, 
microglial CR3 activates nicotinamide adenine dinucleotide phosphate oxidase 
to trigger long-term depression under hypoxia- and LPS-induced brain 
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neuroinflammation (Zhang et al., 2014a). Altogether, these studies suggest that 
complement cascade signaling plays essential roles in synaptic elimination by 
microglial phagocytosis during retinal and brain development. However, 
excessive complement activity may contribute to synaptic loss in Alzheimer's 
disease and schizophrenia. 
 
1.3.4.4 Purinergic receptor (P2R) 
Adenosine-5′-triphosphate/diphosphate (ATP/ADP) released by neurons provide 
energy to promote microglial morphological change, migration, activation, and 
proliferation. Microglia use plasma membrane purinergic receptors to sense and 
respond to extracellular nucleotides such as ATP (P2X4, P2X7, P2Y12), ADP 
(P2Y12, P2Y13) and adenosine (A1, A2a, A2b, A3) in the brain (Davalos et al., 
2005; Haynes et al., 2006; Orr et al., 2009; Sipe et al., 2016). These receptors 
include ionotropic P2X (intrinsic ion channels), metabotropic P2Y, and P1 (G 
protein coupled). Different P2Rs execute various functions. For example, P2Y12 
regulates microglial activation and migration by detection of extracellular ATP 
(Haynes et al., 2006; Ohsawa et al., 2007; Swiatkowski et al., 2016), whereas 
P2X7 induces microglial activation and proliferation (Monif et al., 2009). By 
following ATP/adenosine gradients, P2X7 and P2Y12 help microglia sense and 
elongate their protrusions to the target site (Arnoux et al., 2013; Davalos et al., 
2005; Haynes et al., 2006; Sipe et al., 2016). Upregulation of microglial P2X4 
mediates BDNF synthesis and release, dependent on calcium influx and p38-
mitogen-activated protein kinase signaling (Trang et al., 2009; Ulmann et al., 
2008). CCL2 induces P2X4 expression and promotes P2X4 trafficking from 
intracellular stores to the cell membrane in microglia (Toyomitsu et al., 2012). 
The aforementioned observations suggest that microglial morphological changes 
need the energy supplies by neurons under “resting” and inflammatory states. 
P2Rs on the surface of microglia sense ATP/ADP and initiate P2R signals; the 
activated signaling subsequently promotes microglial activation and movement 
in response to brain microenvironment changes.    
 
1.3.4.5 Brain-derived neurotrophic factor (BDNF) 
Neurotrophic factor BDNF plays a critical role in neuronal survival and 
development. BDNF also participates in long-lasting synaptic plasticity 
associated with hippocampus-dependent memory (Bramham and Messaoudi, 
2005; Lu, 2003). BDNF is initially synthesized as a precursor pro-BDNF, 
consisting of a pro-domain and a mature domain(Hempstead, 2015). BDNF is 
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expressed not only in neurons and astrocytes (Parpura et al., 2010) but also in 
microglia (Trang et al., 2009). Microglial BDNF was first discovered in cell 
cultural medium (Elkabes et al., 1996). It has been shown recently that specific 
deletion of BDNF in microglia inhibited spine formation and decreased motor 
learning (Parkhurst et al., 2013). In addition, early release of BDNF from 
microglia appears to be tightly associated with P2X4 activation in maintaining 
pain hypersensitivity after nerve injury. P2X4R-evoked release and synthesis of 
BDNF depend on extracellular calcium and p38-mitogen-activated protein kinase 
activation (Trang et al., 2009). Microglia control neuronal networks via BDNF-
TrkB signaling and modulate neuronal K+ and Cl- homeostasis, and hence control 
the strength of GABA(A)- and glycine receptor-mediated inhibition (Ferrini and 
De Koninck, 2013). These studies suggest that BDNF in microglia regulate 
microglial activity. Microglial activation, in turn, affects neuronal activity and 
behavioral changes in mice. 
 
1.3.4.6 Triggering receptor expressed on myeloid cells 2 (TREM2) and 
DNAX activation protein of 12 kDa (DAP12) 
TREM2 is a transmembrane glycoprotein that consists of a single extracellular 
immunoglobulin-like domain and a transmembrane region with lysine residues 
(Bouchon et al., 2000; Daws et al., 2001). Although TREM2 was originally 
identified and characterized in human dendritic cells (Bouchon et al., 2001), 
accumulating evidence indicates an important role in bone modeling and brain 
function (Colonna, 2003; Paloneva et al., 2002). In the brain, TREM2 is highly 
expressed in microglia compared to neurons and other glia (Hickman et al., 2013). 
Microglial TREM2 expression varies in a region-specific manner. The lateral 
entorhinal and cingulate cortex have higher levels of TREM2 (Schmid et al., 
2002). TREM2 modulates neuroinflammation (Hickman and El Khoury, 2014; 
Painter et al., 2015) and is a risk gene for late-onset AD (Guerreiro et al., 2013; 
Jonsson et al., 2013). In rodent AD models, the microglial proinflammatory 
response was controlled by TREM2 signaling after LPS stimulation (Wang et al., 
2015). TREM2-deficient microglia were unable to scavenge and phagocytose 
apoptotic neurons in the brain (Jiang et al., 2014; Takahashi et al., 2005). 
TREM2-KO mice showed reduced Aβ clearance (Wang et al., 2015; Yuan et al., 
2016), enhanced neuronal synaptic loss and neuritic damage (Jiang et al., 2014; 
Takahashi et al., 2005; Yuan et al., 2016), and impaired spatial cognition (Jiang 
et al., 2014). Importantly, TREM2-deficient microglia were significantly more 
apoptotic than controls, suggesting that TREM2 is necessary for microglial 
survival (Wang et al., 2015). 
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DAP12, the TREM2 co-receptor, is a short polypeptide consisting of a short 
extracellular tail, a single transmembrane domain, and a cytoplasmic 
immunoreceptor tyrosine-based activation motif. DAP12 is expressed in cells of 
both myeloid and lymphoid origins (Lanier et al., 1998). Knockdown of TREM2 
or DAP12 in microglia induced IL-1β and IL-6 production following LPS, and 
over-expression of full-length or the C-terminal (DAP12-interacting) fragment 
of TREM2 suppressed inflammation (Zhong et al., 2015). Genetic mutations of 
DAP12 and TREM2 result in presenile dementia with bone cysts in Nasu-Hakola 
disease (Paloneva et al., 2000; Paloneva et al., 2002).  
 
Taken together, these studies suggest that TREM2-DAP12 signaling in the 
microglia modulates microglial activation and phagocytosis and cytokines 
production in response to neuroinflammation. The mutations of TREM2 have 
been linked to the Alzheimer's disease. 
 
1.3.4.7 Major histocompatibility complex I (MHCI) and II (MHCII) 
MHC class I molecules are trimeric proteins comprised of a transmembrane 
heavy chain with three α domains, a β2-microglobulin light chain, and a peptide 
bound within the groove formed by two α regions of the heavy chain. The 
classical MHC class I is encoded by three genes, HLA-A, HLA-B, and HLA-C in 
humans, and in mice, H2-b, H2-d, and H2-k. MHC class II molecules are 
heterodimers assembled from two transmembrane chains (α and β). Each chain 
contains two domains (α1-2 and β1-2). The classical MHC class II is encoded by 
three genes, HLA-DR, HLA-DQ, and HLA-DP in humans, and by two genes H2-
a and H2-e in mice (Needleman and McAllister, 2012; Neefjes et al., 2011). 
MHCI and II have been extensively studied in innate and adaptive immune 
responses (Peaper and Cresswell, 2008). Accumulating evidence indicates that 
MHCI plays important roles for neurons in the brain by directly regulating 
synaptic formation and plasticity (Corriveau et al., 1998; Goddard et al., 2007; 
Huh et al., 2000). GWAS studies revealed that MHC locus variants are strongly 
associated with the risk of schizophrenia progression (Debnath et al., 2013; Irish 
Schizophrenia Genomics and the Wellcome Trust Case Control, 2012; Jia et al., 
2012; Stefansson et al., 2009). MHCI is colocalized with postsynaptic protein 
PSD-95 in the dendrites of hippocampal neurons. MHCI interacts with 
presynaptic proteins to guide activity-dependent synaptic formation, which might 
suggest that microglia mediate synaptic pruning through concomitant neural 
activity (Figure 2C) (Corriveau et al., 1998; Datwani et al., 2009; Goddard et al., 
43 
 
2007; Huh et al., 2000). M1-microglia express the pro-inflammatory surface 
marker MHCII (Saijo and Glass, 2011), which was recently shown to be 
specifically associated with depressive-like behavior in rodents (Wachholz et al., 
2016). Altogether, these observations suggest that MHC molecules play a vital 
role in synaptic formation, pruning, and maintenance during brain development. 
Mutations in MHC locus may contribute to the aberrant brain connectivity and 
functions in schizophrenia progression. 
 
1.3.4.8 Inflammatory cytokines (interleukin-1β (IL-1β), interleukin-6 (IL-6) 
and tumor necrosis factor-alpha (TNF-α)) 
Microglia-derived IL-1β, IL-6, and TNF-α can modulate molecular and cellular 
mechanisms sub-serving learning, memory, and cognition under physiological 
conditions and contribute to mood and cognitive dysfunction (de Haas et al., 2007; 
McAfoose and Baune, 2009). For example, induction of LTP promoted IL-1β 
gene expression, whereas blocking IL-1β by an IL-1 receptor antagonist (IL-1RA) 
impaired the maintenance of LTP (Schneider et al., 1998). IL-1β was further 
shown to play an important role in learning and memory formation (Balschun et 
al., 2003; Schneider et al., 1998). Different cytokines may have different effects 
in LTP maintenance, for example, IL-1β supports LTP maintenance, but IL-6 
inhibits LTP maintenance (del Rey et al., 2013). Peripheral administration of LPS 
produces IL-1β and other pro-inflammatory cytokines such as IL-6 and TNF-α 
in the brain (Breder et al., 1994; Gatti and Bartfai, 1993; Laye et al., 1994; Quan 
et al., 1999; van Dam et al., 1992). Administration of IL-1β induced memory and 
cognitive dysfunction, which was mitigated by an IL-1R antagonist and also in 
IL-1R-KO mice (Cibelli et al., 2010). IL-6-deficient mice displayed resistance to 
LPS-induced working impairment (Sparkman et al., 2006). Maternal 
administration of IL-6 induced deficits in PPI and social behavior in the offspring, 
which was prevented by administration of an IL-6 antibody (Smith et al., 2007). 
Furthermore, microglia-derived IL-6 and IL-1? regulate astrocytogenesis during 
brain development (Giulian et al., 1988; Nakanishi et al., 2007) (Figure 2A). In 
comparison, TNF-α is essential for the excitatory synaptic efficacy via 
upregulation of the glutamatergic cell surface AMPA receptor expression 
(Beattie et al., 2002). TNF-α also regulates synaptic scaling (Figure 2C) 
(Stellwagen and Malenka, 2006). Additionally, TNF-α (Babri et al., 2014; Haji 
et al., 2012) and IL-1β (Chiu et al., 2014; Wohleb et al., 2014b) mediate anxiety-
like behavior in different mouse models. Social behavior in mice can be regulated 
by IL-1β (Washington et al., 2015) and IL-6 (Wei et al., 2016). ?
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Of note, pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β are 
increased in the blood and cerebrospinal fluid of first-onset and acute-relapse 
schizophrenia patients and increased pro-inflammatory cytokines and microglial 
activation are associated with schizophrenia symptoms (Miller et al., 2011; 
Potvin et al., 2008; van Berckel et al., 2008).   
 
The aforementioned studies suggest that proinflammatory cytokines released 
from microglia have important roles in regulating synaptic and neuronal activity. 
The disruption of neuronal activities by cytokines may cause cognitive 
dysfunction and deficits in emotion and sociability during brain development, 
leading to neuropsychiatric disorders such as schizophrenia. 
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2. Aims of the study 
Increasing evidence reveals the involvement of microglia and microglia-
associated brain immune genes in neuropsychiatric disorders. This work aimed 
to identify the roles of brain immune genes in anxiety- and sociability-related 
neuropsychiatric disorders by using inbred mouse strains. The specific objectives 
of this study are below: 
 
1. To identify the major brain immune networks associated with behavior and 
brain structural changes among eight inbred mouse strains. 
 
2. To measure the expression of candidate brain immune genes and analyze their 
correlation with social behavior in C57BL/6J(N) and DBA/2J strains. 
 
3. To compare anxiety traits and the expression of cytokines and microglial M1- 
and M2-signature genes among C57BL/6J, FVB/N, DBA/2J, and 129S2/Sv 
strains. 
 
4. To compare the behavior of C57BL/6N and DBA/2J strains in different 
housing conditions as a social stress model and to identify the involved 
neuroendocrine factors. 
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3. Materials and Methods 
The methods used in this study are listed in Table 2. A detailed description of the 
materials and methods can be found in the original publications (I, II, III, & IV). 
 
Table 2. Overview of methods used in this study 
Methods Publication 
Light/Dark test  
 
I, II 
Open-field and Elevated-plus maze tests II 
Resident-intruder test 
 
III, IV 
Pre-pulse inhibition of acoustic startle 
reflex  
 
IV 
Three-chambered sociability test 
 
III 
Social dominance tube test 
 
I 
Forced swimming test 
 
I 
Cognitive test in the IntelliCage I 
Total RNA isolation and quantitative 
polymerase chain reaction (qPCR) 
I, II, III, IV 
Flow cytometry 
 
II 
Serum corticosterone measurement 
 
I 
Inbred mouse brain microarray data 
processing and expression analysis 
III 
Functional gene annotation and clustering 
of differentially expressed brain genes  
III 
Correlation analysis of brain immune 
genes with mice behaviors and brain 
morphology 
III 
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4. Results and Discussion 
4.1 Anxiety-, sociability- and sensorimotor gating-related behavior in 
inbred mouse strains (I, II, III, & IV) 
 
4.1.1 Anxiety traits across four inbred mouse strains: DBA/2J mice are more 
anxious than C57BL/6J mice 
To select appropriate inbred strains in our study, we searched for anxiety traits of 
different inbred strains by exploring the mouse phenome database (MPD) and 
focused on four inbred strains: C57BL/6J, FVB/N, DBA/2J, and 129S1/Sv. We 
further compared their anxiety-like behavior by the elevated-plus maze, 
light/dark, and open-field tests. Compared to DBA/2J or 129S2/Sv males, 
C57BL/6J or FVB/N males stayed longer in the open arms of elevated-plus maze, 
were more active in entering into the light zone of light/dark, and spent more time 
and travelled longer distances in the center of open-field (II: Figure 1). Although, 
our results suggest that DBA/2J and 129S2/Sv strains were more anxious than 
the C57BL/6J and FVB/N strains. These data provided the foundation for further 
studies on how anxiety traits affect microglial activation and polarization. 
 
4.1.2 Deficient sociability in DBA/2J compared to C57BL/6J(N) 
As DBA/2J and C57BL/6J(N) are commonly used inbred strains in mouse 
behavioral tests, we compared the sociability between both sexes of these strains. 
In the resident-intruder and three-chambered sociability tests, DBA/2J mice spent 
less time with their peers compared to C57BL/6J or C57BL/6N mice (III: Figure 
2 & IV: Figure 1). The result suggests that the C57BL/6J(N) strain is more social 
than the DBA/2J strain.  
 
Social withdraw is a core symptom in schizophrenia and autism. Social 
withdrawal or deficit is regarded as a negative symptom in schizophrenia. Due to 
the differences in social behavior between C57BL/6 and DBA/2 mice, it may be 
necessary to study the genetic background contributions of these strains to social 
deficits. These results may provide information on understanding the social 
withdrawal symptom in schizophrenia. The social behavioral data provided a 
foundation to study the association between strain-specific brain immune genes 
and social behavior.  
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4.1.3 Impaired sensorimotor gating in female DBA/2J compared to 
C57BL/6N  
A deficit in sensorimotor gating is a cognitive symptom in schizophrenia. The 
prepulse inhibition startle response (PPI) test was used to compare sensorimotor 
gating in female C57BL/6N and DBA/2J mice. Female DBA/2J mice displayed 
an impairment in prepulse inhibition of startle response compared to C57BL/6N 
mice (IV: Figure 1). The data suggests that female DBA/2J mice showed 
impaired sensorimotor gating compared to C57BL/6N mice. 
 
Our result is consistent with previous studies (Olivier et al., 2001; Singer et al., 
2009). Similar to our observation, male DBA/2J mice were also deficient in PPI 
as compared to C57BL/6J mice (Singer et al., 2009). Gender differences in PPI 
were not found in either strain in another study (Willott et al., 2003). Our results, 
together with other studies, suggest that gender does not affect the differences in 
sensorimotor gating in DBA/2J and C57BL/6 mice.   
 
Although social deficits and impaired sensorimotor gating endophenotypes in 
DBA/2J mice resemble several symptoms in schizophrenia, the predictability 
value of the data generated from DBA/2J mice warrants attention. For example, 
although DBA/2J mice showed impaired PPI, DBA/2J mice did not show 
enhanced clozapine (an antipsychotic medication) response in PPI test (Singer et 
al., 2009). This suggests that the behavioral data obtained from DBA/2J mice 
may be interpreted incorrectly; other approaches or animal models for behavior 
measurement may still be needed.  
 
4.1.4 Mixed housing increases anxiety-like behavior in female C57BL/6N, 
but not in DBA/2J mice  
The social environment affects physiology and behavior in humans and rodents. 
Alterations in the social environment provide an effective way to change 
behavior of humans and rodents. We investigated whether a change in social 
environment by housing DBA/2J and C57BL/6N mice together would change 
their anxiety-like and other behavior. Since male mice fight each other to display 
their social dominance in one group when mix-housed together, female mice 
were chosen in our study. We found that C57BL/6N mice from both separated 
and mixed groups spent more time in the light compartment in the light/dark test 
compared to DBA/2J mice (I: Figure 4B). Of interest, within the same strain, 
mixed housing made C57BL/6N mice spend less time in the light zone compared 
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with mice housed separately, whereas mixed housing did not affect DBA/2J mice 
(I: Figure 4B).  
 
Taken together, these results suggest that the C57BL/6N strain is less anxious 
than the DBA/2J strain, which is not affected by mixed housing condition. 
However, C57BL/6N mice display more anxious behavior and are more sensitive 
to mixed housing conditions compared to C57BL/6N mice in a separated housing 
condition. This suggests that the social environment significantly affects the 
stress response ability in C57BL/6N mice. 
 
4.1.5 Mixed housing decreases social dominance in female C57BL/6N, but 
not in DBA/2J mice 
We also performed the tube test to measure social dominance between the two 
different strains in mixed versus separated housing conditions. Under the same 
housing condition, C57BL/6N mice won more rounds than DBA/2J when 
C57BL/6N and DBA/2J mice were placed in the same tube (I: Figure 3B). When 
the same mouse strain from the mixed housing and separated housing were 
placed in the same tube, separate-housed C57BL/6N mice won more rounds than 
mix-housed mice. However, no difference was observed in DBA/2J mice, 
suggesting that mixed housing made C57BL/6N mice, but not DBA/2J mice, 
more submissive (I: Figure 3B).  
 
These data (I: Figure 3B and 4B) indicate that C57BL/6N mice were more 
sensitive to react to and to cope with changes in the social environment compared 
to DBA/2J mice. Our results corroborate earlier observations that C57BL/6N and 
DBA/2J mice exhibit different coping styles (refer to specific efforts in behavior 
and psychology) to stressful contexts (Cabib et al., 2002). DBA/2 mice display 
increased anxiety levels in light/dark and elevated-plus maze tests after chronic 
restraint stress (Mozhui et al., 2010) and when under long-term individual 
housing conditions (Voikar et al., 2005) compared to C57BL/6 mice, suggesting 
that DBA/2 mice use a passive coping style in response to stress. On the other 
hand, DBA/2 mice show decreased immobility in a forced swimming test, 
suggesting that DBA/2 are desensitized to stress-induced behavioral despair and 
depression-like behavior (Cabib et al., 2002; Voikar et al., 2005). Our data also 
suggest that coping with stress made C57BL/6N mice more anxious. Clinical 
reports have also found that, during adolescence and early adulthood, healthy 
siblings of patients with autism and schizophrenia had an increased risk for 
developing cognitive and social deficits in comparison with siblings of healthy 
persons (Bowman et al., 2014; O' Brien et al., 2009; Shaked et al., 2006). Long-
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term interaction with stressed persons caused stress and behavioral alteration in 
healthy caretakers (Steele et al., 2010). Both rodent and human studies therefore 
provide useful guidelines for caring of neuropsychiatric patients.  
  
Anxiety, sociability, and sensorimotor gating are three important parameters 
broadly used to evaluate neuropsychiatric-like behavior in rodents. These 
behavioral data provide a rationale for further studies in strain-specific brain 
immune genes and their association with social behaviors, and how anxiety 
affects microglial activation and polarization. In addition, it is interesting to 
investigate how social stress condition regulates neuropeptide to regulate 
anxiety-like and social behavior.  
 
4.2 Brain immune genes associated with social behaviors of inbred mice (III 
& IV) 
 
4.2.1 Differential expression of brain immune genes and prediction of their 
association with mouse endophenotypes across eight inbred strains 
Complex immune-brain interactions affect neuronal development and brain 
function. Increasing evidence highlights the involvement of immune dysfunction 
in the etiological progression of neuropsychiatric disorders (see 1.3.2.4). To 
determine whether immune genes are expressed in a strain-specific manner, we 
compared the brain gene expression data collected using Affymetrix microarray 
assays. Male mice from eight commonly used inbred strains 129S1/SvImJ, A/J, 
BALB/cByJ, C3H/HeJ, C57BL/6J, DBA/2J, FVB/NJ, and SJL/J were chosen for 
further bioinformatics studies. These strains show differences in their emotional, 
exploratory, and cognitive functions. The eight inbred strains belong to the 
priority strains in the Mouse Phenome Project, as these strains are commonly 
used strains in behavioral tests. Altogether, 2983 differentially expressed probe 
sets (representing 2584 mouse genes identified in the DAVID database) among 
the eight strains were discovered. To better grasp the molecular functions, 
cellular localizations, and biological processes that they are involved in, we 
retrieved a list of these genes and imported it into DAVID (a 
major bioinformatics initiative to unify the representation of gene and gene 
product) database for functional annotation clustering based on their gene 
ontology terms.  
 
Among the 2584 genes, we found altogether 83 immune genes, out of which 23 
genes have functions in innate immune response. To better understand the 
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functional relationships of these 23 immune genes, we further used the online 
analysis tool STRING v9.1 to identify protein-protein interaction networks 
among these genes. Five clusters were identified, including coagulation factor II 
receptor (F2r), MHC class I family (H2-d1 and H2-k1), nuclear factor NF-κB 
signaling modulators (Tollip and Tnfsf13b), antiviral molecules (Polr3b, Polr3c 
and Polr3f), and complement components and receptors (C1qb and Cd47). In 
addition, Cx3cl1 has a strong association with coagulation factor II F2 (III: Figure 
1). The powerful bioinformatics methods used predicted that the five significant 
gene clusters are involved in brain innate immune responses among the eight 
inbred strains (Figure 3.). These results provided important information regarding 
whether these innate immune genes are correlated with mice behavior, and 
suggested that these genes might modulate the functions of innate immune cells 
in the brain, such as microglial function. 
 
 
 
 
 
Figure 3. Protein-protein interaction network analysis of differentially 
expressed innate immune genes among inbred mouse strains with 
STRINGv9.1. Five significant clusters (marked by black squares) were 
identified from the 23 immune genes (marked by red squares) discovered through 
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microarray analysis of brain genes in 8 inbred mouse strains. The confidence of 
interaction is represented by the thickness of the line (Ma et al., 2015b).  
 
To further elucidate the functional meaning of these 23 immune genes and to 
identify the types of behavior they may be involved in, we explored the mouse 
phenome database (MPD), which contains a vast repository of various biological 
data on these strains. With correlation analysis, we found a list of significantly 
correlated phenotypes (anxiety, exploratory-locomotion, fear conditioning, and 
the length of corpus callosum) for six genes (C1qb, Cx3cl1, H2-d1, H2-k1, 
Polr3b, and Tnfsf13b). The relative microarray expression levels of these six 
immune genes are summarized (III: Table 1). Among them, we found that several 
genes, including C1qb, Cx3cl1 and H2-d1, have the highest expression levels in 
the C57BL/6J strain. 
 
Since MPD currently provides very limited data on mouse social behavior per se, 
we focused on the data that were most related to social behavior. Our analysis 
revealed that these genes may be significantly correlated with various behavior 
(summarized in III: Table 2). For example, the MHC gene H2-k1 is positively 
correlated with anxiety, and H2-d1 and H2-k1 are positively correlated with the 
exploratory activity of animals (MPD #94) (Fraser et al., 2010). Furthermore, 
C1qb, Cx3cl1, and Polr3b are negatively correlated with the time an animal 
spends near the walls of a conditioning chamber after contextual/cued fear 
conditioning (MPD #468) (Park et al., 2011). Such predictive data suggest that 
genes like H2-d1, H2-k1, C1qb, Cx3cl1, and Polr3b may be involved in 
behavioral processes related to social activities of animals.  
 
Another interesting finding was that many of these immune genes are correlated 
with the brain structural morphology (III: Table 2) (MPD #108) (Wahlsten et al., 
2006). For instance, Cx3cl1 is positively correlated with the length of the corpus 
callosum (CC). In contrast, the proinflammatory cytokine Tnfsf13b is negatively 
correlated with the CC length. A detailed correlation analysis among the eight 
strains showed that the C57BL/6J strain expresses the highest levels of Cx3cl1 
and the lowest level of Tnfsf13b, while containing the longest CC. In comparison, 
the 129S1/SvImJ strain expresses the lowest levels of Cx3cl1 and a relatively 
higher level of Tnfsf13b, while containing the shortest CC. CC is an essential 
brain structure associated with schizophrenia and autism pathology. Inbred 
strains 129 and BTBR are entirely absent of CC (Kusek et al., 2007). TNFSF13b 
(BAFF) belongs to the TNF superfamily, which acts as a potent B-lymphocyte 
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activator in the immune response (Tangye et al., 2006). Interestingly, recent 
GWAS studies revealed that genes of B lymphocytes lineage and B-cell 
activation-related immune genes are associated with the risk for developing 
schizophrenia (Network and Pathway Analysis Subgroup of Psychiatric 
Genomics, 2015; Schizophrenia Working Group of the Psychiatric Genomics, 
2014). The correlation analysis on these brain immune genes with CC length 
suggests that TNFSF13b and CX3CL1 might modulate microglial activity, which 
affect neuronal survival and differentiation during the brain development. This 
in turn leads to differences in brain structure, particularly CC length, among the 
eight inbred mice. The brain morphological changes in different inbred strains 
could provide insight in understanding the behavioral differences among them.   
 
4.2.2 Female DBA/2J mice express more proinflammatory Il1b and Il6, but 
less Cx3cl1 in the cortex, and differentially express several other immune 
genes than female C57BL/6N mice. 
In paper IV, we reported significant differences in the cognitive and emotional 
responses of female C57BL/6N and DBA/2J mice towards social stress. We did 
not observe a clear pattern of strain-specific molecular changes in the 
neuroendocrine system that could explain the behavioral differences (see 4.1.4, 
4.1.5 & 4.4). We thus further studied the differential expression of brain immune 
genes in these female C57BL/6N and DBA/2J mice, to elucidate the potential 
importance of brain immune genes contributions to behavioral changes.  
 
The differences in sociability and sensorimotor gating behavior were identified 
between female C57BL/6N and DBA/2J mice (see 4.1.3). We then compared 
canonical proinflammatory cytokines in three brain regions (hypothalamus, 
hippocampus, and cortex) and found that female DBA/2J mice expressed 
significantly higher Il6 in the hypothalamus and cortex. Il1b levels were higher 
in the cortex of DBA/2J, while no difference in the hippocampus was observed 
(IV: Figure 2). We further compared other important brain immune genes such 
as Tnfsf13b, C1qb, Cx3cl1, and Cd47. Of interest, DBA/2J mice expressed higher 
levels of Tnfsf13b in the cortex and hippocampus and higher levels of Cd47 in 
the hippocampus, but lower levels of Cx3cl1 in the cortex compared to 
C57BL/6N mice. However, there were no differences in the levels of Tnfsf13b, 
Cd47, and Cx3cl1 expression in the hypothalamus (IV: Figure 3) (Figure 4.).  
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Figure 4. Differences in microglia activation and brain immune gene 
expressions among inbred mouse strains including C56BL/6J(N), FVB/N, 
DBA/2J, and 129S2/Sv. Detailed results are discussed in these sections 
(microglial activation and signature genes expression, section 4.3; brain immune 
gene expression, sections 4.2.2 & 4.2.3). NA indicates no available data.  
 
We found that C1qb was significantly downregulated in the hippocampus of 
DBA/2J mice, as compared to C57BL/6N mice. Additionally, the expression of 
C1qb was positively correlated with the time spent in social interaction processes 
in DBA/2J mice (see 4.2.3). Our data suggest that C1qb-mediated synaptic 
pruning may be less effective in the brains of DBA/2J mice, thus leading to their 
poorer sociability. Furthermore, our result on the lower levels of Cx3cl1 
expression in the cortex of DBA/2J mice provided further evidence on the 
importance of CX3CL1 in regulating microglial activation and social behavior in 
animals. CD47, an integrin-associated protein, is broadly expressed in the brain 
(Murata et al., 2006; Numakawa et al., 2004). The interaction between CD47 and 
its receptor SIRPα regulates microglial activation and neuroinflammation in CNS 
disorders (Brown and Frazier, 2001; Tian et al., 2009; Zhang et al., 2015). In this 
regard, the higher levels of Cd47 expression in the hippocampus of DBA/2J mice 
implies a potential role of CD47 in the regulation of social behavior. 
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4.2.3 Differentially expressed brain immune genes C1qb, H2-d1, Polr3b, and 
Tnfsf13b and their association with social behavior in male DBA/2J and 
C57BL/6J mice. 
To further measure the predicted brain immune gene expression as mentioned 
above, we compared the expression levels of six immune genes (C1qb, Cx3cl1, 
H2-d1, H2-k1, Polr3b, and Tnfsf13b) in the PFC, hippocampus, and 
hypothalamus of C57BL/6J and DBA/2J strains (III: Figure 3). Of particular 
interest, H2-d1 was significantly decreased in these brain regions of DBA/2J 
mice compared to C57BL/6J mice (III: Figure 3A). Similarly, C1qb was 
decreased significantly in the hippocampus of DBA/2J mice (III: Figure 3B). In 
contrast, DBA/2J mice expressed significantly higher Tnfsf13b in the PFC (III: 
Figure 3C) and higher Polr3b in the hippocampus (III: Figure 3D) than C57BL/6J 
mice (Figure 4.). These results suggest that differential expression of several 
brain immune genes, including C1qb, H2-d1, Polr3b, and Tnfsf13b, may display 
a brain region-dependent pattern. These genes might constitute a complex gene 
network to modulate social behavior in mice.  
 
We also analyzed the correlations between the mRNA levels of immune genes 
(C1qb, H2-d1, Polr3b, and Tnfsf13b) with social behavior of C57BL/6J and 
DBA/2J mice in the resident-intruder and three-chambered tests (III: Figure 4). 
Interestingly, the mRNA level of C1qb in the hippocampus was positively 
correlated with the percentage of social time in the three-chambered social test in 
DBA/2J mice (III: Figure 4A) but not in C57BL/6J mice (III: Figure 4B). By 
combining bioinformatic methods with targeted experimental approaches, we 
discovered that the immune gene C1qb from predicted gene networks may be 
associated with social behavior in inbred DBA/2J mice. Complement localized 
to synapse mediate synaptic pruning during early postnatal retinal development 
(Schafer et al., 2012). C1q is an important protein to initiate complement cascade, 
but mice deficient in complement protein C1q display large sustained defects in 
CNS synapse elimination during retinal development (Bialas and Stevens, 2013; 
Stevens et al., 2007). C1q deficiency in mice contributes to synaptic loss in AD 
mouse model (Hong et al., 2016). Our results showed that decreased C1qb level 
in the hippocampal of DBA/2J mice and significant correlation between C1qb 
expression and social behavior in DBA/2J mice. These results together with 
previous findings by others suggest that decreased C1qb level in the hippocampus 
may cause deficits in synaptic elimination and social behavior in DBA/2J mice. 
Although further investigation on the association between deficits in synaptic 
elimination and social behavior changes in DBA/2J mice will be necessary, our 
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current results may provide indirect evidence on C1q contribution to social 
behavior.  
 
In addition, when the data on H2-d1 expression in DBA/2J and C57BL/6J mice 
were combined, the mean mRNA level of H2-d1 in three brain regions (PFC, 
hippocampus, and hypothalamus) was positively correlated with the time spent 
during social interaction processes (data not shown). However, no significant 
correlation of Tnfsf13b and Polr3b expression with social behavior were 
observed.  
 
The MHCI gene H2-d1 was differentially expressed in the brain of inbred mouse 
and was associated with animal social behavior. This finding corroborates the 
important neurobiological functions of MHCI and demonstrates the validity of 
our approach in identifying immune-related genetic mechanisms of social deficits. 
Although we did not observe a correlation between Polr3b and Tnfsf13b 
expression with social behavior, differential expression of these genes may 
elucidate their potential neurobiological functions. Interestingly, POLR3A or 
POLR3B mutations are associated with neurodegenerative hypomyelinating 
leukodystrophy spectrum disorders in humans (Bernard and Vanderver, 1993; 
Daoud et al., 2013; Tetreault et al., 2011). Additionally, POLR3B has been 
shown to disturb the purine metabolism and contribute to AD (Ansoleaga et al., 
2015). Our results, in combination with other studies, suggest that POLR3B and 
TNFSF13b might modulate other brain functions such as learning and memory, 
although these genes do not regulate the social behavior in mice. In the fear 
conditioning test, Polr3b expression is predicted to be associated with time spent 
near the chamber walls, it is therefore necessary to further investigate POLR3B 
function in learning and memory. Interestingly, Tnfsf13b expression is predicted 
to be associated with CC length. Corpus callosum (CC) is an essential brain 
structure associated with schizophrenia and autism pathology. Inbred strains 129 
and BTBR are entirely absent of CC (Kusek et al., 2007). TNFSF13 might 
regulate brain structure to affect brain function. Therefore, POLR3B and 
TNFSF13b can be studied in other mouse models such as schizophrenia, AD, and 
autism. 
 
Overall, several limitations need to be considered in our studies III and IV. First, 
although several significant correlations were found between gene expression 
and time spent during social interaction, these genes may not be causative for 
aberrant social behavior. Therefore, further investigation of these immune genes 
57 
 
in genetically modified mouse models is necessary. Second, several 
discrepancies exist between microarray and RT-qPCR data presented here. For 
example, we were unable to validate the Cx3cl1 and H2-k1 expression levels in 
the hippocampus and hypothalamus in study III. This could be due to the 
possibility that microarray detection of Cx3cl1 and H2-k1 expression in the whole 
brain might not parallel gene expression in separate brain regions. Finally, 
although gender differences in behavior is an important issue, a solid conclusion 
on gender effects on behavior cannot be drawn from our current data. However, 
gender-specific differences in expression of brain immune genes seem to exist. 
For example, cytokines Il1b, Il6, and Tnf were more abundant in the 
hypothalamus of male DBA/2J (II: Figure 6), as discussed in section 4.3.1, but 
only higher levels of Il6 expression in the hypothalamus of female DBA/2J mice 
were found (IV: Figure 2, section 4.2.2). Further studies should therefore use 
more stringent design paradigms to compare and address the gender issue on 
correlations between immune gene expression and behavior in mice. 
 
4.3 Brain immune genes associated with microglial polarization in inbred 
mouse strains following LPS challenge (II) 
 
4.3.1 Differential expression of pro-inflammatory cytokines Il1b, Il6 and Tnf 
in the hypothalamus among four inbred strains without LPS challenge 
As described above, we observed DBA/2J and 129S2/Sv mice were more anxious 
compared to C57BL/6J and FVB/N mice (see 4.1.1). We further detected 
differentially expressed immune genes among these strains (see 4.2.3). As several 
proinflammatory cytokines are involved in the control of emotional and affective 
behavior, including anxiety-like behavior in rodents (Bilbo and Schwarz, 2012; 
Dantzer et al., 2008; Yirmiya and Goshen, 2011), we next investigated whether 
high-anxiety strains express more canonical proinflammatory cytokines Il1b, Il6 
and Tnf in the hypothalamus with or without LPS challenge. The hypothalamus 
was chosen because of its intimate association with stress response (Glaser and 
Kiecolt-Glaser, 2005), and also due to its sensitivity to LPS stimulation in the 
blood circulation due to less intact BBB (Lacroix et al., 1998). Since levels of 
Il1b, Il6, and Tnf are very low in the naïve mouse brain, and even mild and 
transient handling stress might enhance gene expression, PBS-injected mice were 
used as controls. We found that DBA/2J mice expressed higher Il1b, Il6, and Tnf 
than the other strains (II: Figure 6A-C) (Figure 4). In addition, we performed 
gene differential expression analysis on whole brain microarray data and 
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compared the expression of inflammatory genes (including cytokines, 
chemokines and their receptors, and genes during microglial activation) among 
four inbred strains. We found that a majority of these genes were expressed at the 
lowest level in C57BL/6J strain, but at the highest level in 129S1/Sv strain (II: 
Table2). These results suggest that the more anxious strain highly expresses 
cytokines, chemokines and their receptors, and microglial activation-associated 
genes. On the other hand, these data imply that 129S1/Sv mice may induce 
microglial activation via other signaling pathways besides those mediated by 
canonical cytokines. 
 
4.3.2 Differential expression of microglial activation-associated M1 and M2 
signature genes in the hypothalamus among four inbred strains following 
LPS challenge 
Following LPS challenge, expression of Il1b, Il6, and Tnf in the hippocampus 
and hypothalamus were all significantly upregulated among the four inbred 
strains, regardless of their anxiety traits (data not shown). This implies that these 
cytokines do not reflect strain-specific brain immune responses following LPS 
challenge, and other candidate signature genes should be investigated further. We 
therefore compared the microglial polarization (M1- and M2-type) signature 
genes nitric oxide synthase 2 (Nos2), Arg1, and Chi3l3 in the hypothalamus after 
LPS challenge. Compared to C57BL/6J and FVB/N mice, DBA/2J and 129S2/Sv 
mice preferentially expressed the M1 gene Nos2, instead of the M2 genes Arg1 
and Chi3l3 (II: Figure 6D-E, 6G). The ratio of Nos2 to Arg1 were therefore higher 
in the DBA/2J and 129S2/Sv mice than in C57BL/6J and FVB/N mice (II: Figure 
6F). Corroborating our qPCR results, we also found that the amount of CD11bhi-
reactive microglia and the polarization parameter (such as the microglial M1/M2 
ratio detected by flow cytometry) were more pronounced in the high-anxiety 
strains DBA/2J and 129S2/Sv after LPS challenge (II: Figure 3B and 4B) (Figure 
4.). Notably, by aligning microglial M1/M2 ratios with behavioral data from the 
MPD database among C57BL/6J, FVB/N, DBA/2J and 129S/Sv strains, 
significant correlations between microglial M1/M2 ratios with anxiety-related 
behavior, social behavior, and brain structure were found (II: Figure 7A-D). This 
suggests that polarization of microglia may affect animal behaviors and brain 
development. 
 
Taken together, these data demonstrate that high-anxiety strains preferentially 
express pro-inflammatory cytokines in the brain without LPS challenge and pro-
inflammatory M1 signature genes in the brain following LPS challenge. Under 
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LPS stimulation, peripheral cytokines are significantly increased and are sensed 
by their receptors in the hypothalamus, which further activates microglia and 
induces microglial polarization. We only observed that canonical cytokine 
expression exhibits a strain-specific pattern in PBS-injected control mice but not 
in LPS-challenged mice. This suggests that LPS induces a large amount of 
hypothalamic cytokine production, and the strong effect of cytokines produced 
from LPS challenge might override the weak effect of the cytokines produced by 
the inbred mouse anxiety traits. 
 
4.4 Neuroendocrine-mediated molecular mechanisms of the responses to 
social stress in female C57BL/6N and DBA/2J mice (I) 
 
4.4.1 Mixed housing induces higher levels of serum corticosterone in both 
C57BL/6N and DBA/2J strains, but attenuates glucocorticoid receptor 
Nr3c1 expression in the C57BL/6 hippocampus and cortex. 
Stress activates the HPA axis to provoke the release of corticosterone, which 
targets the hippocampus and hypothalamus to modulate anxiety and social 
behavior in response to stressful stimuli (McEwen, 2007).  
 
Since mixed housing induced behavioral changes in social anxiety and social 
dominance in a strain-dependent manner (see 4.1.4 and 4.1.5), we decided to 
investigate whether these behavioral changes were due to the strain-dependent 
release of the stress hormone corticosterone. We found that mix-housed 
C57BL/6N and DBA/2J mice displayed higher levels of serum corticosterone 
compared to separate-housed mice (I: Figure 5A). The data suggest that mixed 
housing induced a stressful social environment for both C57BL/6N and DBA/2J 
strains. Furthermore, both strains showed a similar extent of the HPA response. 
We next investigated whether GR Nr3c1 expression was affected by mixed 
housing conditions. Nr3c1 expression levels in both the hippocampus and the 
cortex were significantly decreased in mix-housed C57BL/6N mice compared to 
separate-housed C57BL/6N mice. Mix-housed DBA/2J mice showed increased 
levels of Nr3c1 expression in the cortex compared to separate-housed DBA/2J 
mice (I: Figure 5B), implying that mixed housing desensitized an inhibitory 
feedback of GRs in C57BL/6N mice in response to stress.  
 
Abnormal corticosterone levels and expression of GRs is associated with stress-
related neuropsychiatric disorders. For example, patients with major depressive 
disorder have impaired GR expression, possibly due to hyperactivity of the HPA 
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axis (Holsboer, 2000; van Rossum et al., 2006). Mice that overexpress GR can 
serve as a model for post-traumatic stress disorder (Chourbaji et al., 2008). GR-
deficient heterozygous mice had an altered predisposition for depressive-like 
behavior and enhanced HPA axis regulation when subjected to stress. Mice with 
GR overexpression displayed a reduced depressive-like behavior after stress 
exposure, and an enhanced HPA system negative feedback regulation. (Ridder et 
al., 2005).  Based on these  studies on the hyperactivity of HPA and GR 
expression deficits, decreased Nr3c1 expression levels in both the hippocampus 
and the cortex of mix-housed C57BL/6N mice might explain (due to impaired 
GR inhibitory feedback) the increased anxiety and social submissiveness 
compared to separate-housed mice. Additionally, the increased expression of GR 
in the cortex of DBA/2J mice induced by mixed housing suggests that GR 
negative feedback on HPA axis in DBA/2J mice might be enhanced in response 
to stress. This result further suggests DBA/2J mice may use positive coping 
styple in reponse to social environmental stress.    
 
4.4.2 Expression of arginine vasopressin (AVP) and oxytocin (OXT) 
receptors in the cortex are strain-dependent between C57BL/6N and 
DBA/2J strains 
We next investigated arginine vasopressin receptor 1a (Avpr1a) and oxytocin 
receptor (Oxtr) expression in the brain. Both receptors were expressed in a strain-
dependent manner (I: Figure 7), with the lower levels of Avpr1a in the cortex of 
DBA/2J mice compared to C57BL/6N mice under mixed housing conditions (I: 
Figure 7A). However, Oxtr was higher in the hippocampus under mixed housing 
conditions and in the hypothalamus under separated housing conditions in 
DBA/2J mice than in C57BL/6N mice (I: Figure 7B). 
 
AVP and OXT are involved in both social behavior in rodents and social 
deficiencies in neuropsychiatric disorders in humans (Benarroch, 2013; Ebstein 
et al., 2012). In humans, four signal nucleotide polymorphisms located in the 
OXTR gene of 195 Han Chinese autism trios were significantly associated with 
autism (Wu et al., 2005). Aditional studies revealed that the OXTR gene locus is 
associated with autism (Liu et al., 2010; Ylisaukko-oja et al., 2006). The AVPR1a 
reporter region is associated with social impairment in autism (Kim et al., 2002). 
Human studies revealed the association between AVPR1a and two aspects (self-
presentation and sibling relationship) of social behavior (Buhrmester and 
Furman, 1990; Lennox and Wolfe, 1984). Social deficits is a major symptom in 
autism (American Psychiatric Association DSM-5 Task Force., 2013). These 
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human genetic association studies in autism patients suggest that OXT and AVP 
may play vital roles in modulating social behavior. Both AVPR1a-KO and 
OXTR-KO mice display impaired social behavior, including imparied social 
recognition and elevated aggressive behavior (Bielsky et al., 2004; Takayanagi 
et al., 2005). Accordingly, the observation that mix-housed C57BL/6N mice 
expressed a higher level of cortical Avpr1a was consistent with the social 
dominant phenotype of C57BL/6N mice. However, the fact that Oxtr expression 
was lower in C57BL/6N mice than DBA/2J mice was inconsistent with their 
social behavior. Our results suggest that the expression of these receptors is strain 
specific and may not be directly regulated by housing conditions. The differential 
expression in both receptors of the two strains indicates that AVP and OXT may 
play essential but different roles in the stress response and in modulating social 
behavior. 
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5. Conclusions  
Immune cell involvement in healthy brain function and in brain diseases, 
including neuropsychiatric disorders, have been actively studied in the past two 
decades. Molecular mechanisms are being investigated with the assistance of 
more precise and powerful in vitro molecular and cellular approaches and in vivo 
animal studies. In this thesis, brain immune genes and brain immune gene 
networks were investigated using inbred mouse strains that resemble some 
symptoms in neuropsychiatric disorders, such as anxiety and social deficits. The 
main conclusions are the following: 
1. Inbred mouse strain DBA/2J is more anxious than the C56BL/6J(N) strain 
and displays schizophrenia-related deficits in sociability and sensorimotor 
gating. Mixed housing induces social stress, which in turn worsens anxiety-
like and social behavior in mix-housed female C56BL/6N mice but not in 
DBA/2J mice.  
 
2. By bioinformatics analysis of brain microarray data, six immune genes 
including C1qb, Cx3cl1, H2-d1, H2-k1, Polr3b and Tnfsf13b were associated 
with mouse behavioral (anxiety, exploratory-locomotion, and fear 
conditioning) and brain morphological features (the length of corpus 
callosum) among eight inbred mouse strains. 
 
3. DBA/2J mice have lower levels of hippocampal C1qb and H2-d1, but higher 
levels of cortical Tnfsf13b compared to C57BL/6J(N) mice. In particular, 
C1qb is correlated with the time spent in social interaction processes in 
DBA/2J mice, suggesting that complement component C1qb plays a vital role 
in modulating mouse social behavior. 
 
4. The canonical proinflammatory cytokines Il1b, Il6, and Tnf and M1-type 
microglial signature genes Nos2 are abundantly expressed in the 
hypothalamus of DBA/2J and 129S2/Sv mice compared to the less anxious 
C57BL/6J and FVB/N mice, suggesting that proinflammatory cytokine 
production and microglial M1-type polarization contribute to anxiety traits in 
inbred mice. 
 
5. Social stress upregulates corticosterone in both C57BL/6N and DBA/2J mice, 
but the expression of Nr3c1 in C57BL/6N mice is attenuated under mixed 
housing conditions. Additionally, mix-housed C57BL/6N mice expressed a 
higher level of cortical Avpr1a, but a lower level of Oxtr than mix-housed 
DBA/2J mice, suggesting that C57BL/6N mice use passive coping style 
(impaired GR inhibitory feedback) in response to social stress. 
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